Tokushima University / Educator and Researcher Directory --- Tomotake, Masahito

Field of Study

○	Medicine

Subject of Study

○	精神医学，精神保健

Book / Paper

Book:

1.	Masahito Tomotake, Takeo Tominaga and Tetsuro Ohmori : 睡眠障害(不眠症), 株式会社中外医学社, Feb. 2023.
2.	Masahito Tomotake : 摂食症, 株式会社中外医学社, Feb. 2023.
3.	Masahito Tomotake : 薬物療法と並行して行う心理社会的治療, 株式会社中外医学社, Feb. 2023.
4.	ジャネットトレジャー, グレインスミス, アナクレイン, 中里道子, Masahito Tomotake and 水原祐起 : モーズレイモデルによる家族のための摂食障害こころのケア原著2版, NANZANDO Co.,Ltd., Oct. 2022.
5.	ウルリケシュミット, ヘレンスタータップ, ジャネットトレジャー, 中里道子, Masahito Tomotake and 水原祐起 : モーズレイ神経性やせ症治療 MANTRAワークブック, NANZANDO Co.,Ltd., May 2021.
6.	Tetsuya Tanioka, Masahito Tomotake, Yuko Yasuhara and Kyoko Osaka : メディカルスタッフのための精神医学, 中外医学社, 東京都新宿区, Jan. 2021.
7.	Masahito Tomotake : 摂食障害, 株式会社中外医学社, Jan. 2021.
8.	Masahito Tomotake : 特定のパーソナリィティ障害, 株式会社中外医学社, Jan. 2021.
9.	Masahito Tomotake : 精神療法, 株式会社中外医学社, Jan. 2021.
10.	Masahito Tomotake : 摂食障害(2)神経性過食症, 株式会社中外医学社, 東京, Jun. 2016.
11.	Masahito Tomotake : 摂食障害(1)神経性やせ症, 株式会社中外医学社, 東京, Jun. 2016.
12.	Masahito Tomotake and Takeo Tominaga : 睡眠障害(不眠症), 株式会社中外医学社, Jun. 2015.
13.	Masahito Tomotake and Takeo Tominaga : 睡眠障害．よくわかる精神科治療薬の考え方,使い方(3版), 株式会社中外医学社, Jun. 2015.
14.	Masahito Tomotake : 摂食障害．よくわかる精神科治療薬の考え方,使い方(3版), 株式会社中外医学社, Jun. 2015.
15.	Masahito Tomotake : 薬物療法と並行して行う心理社会的治療．よくわかる精神科治療薬の考え方,使い方 (3版), 株式会社中外医学社, Jun. 2015.
16.	ジャネットトレジャー, ウルリケシュミット, パムマクドナルド, 中里道子 and Masahito Tomotake : モーズレイ摂食障害支援マニュアル -当事者と家族をささえるコラボレーション・ケア-, 金剛出版, May 2014.
17.	Masahito Tomotake and 大森哲郎 : 脳とこころのプライマリケア6 幻覚と妄想．Ⅴ章:臨床各科で遭遇する幻覚妄想．泌尿・生殖器系, シナジー, Nov. 2011.
18.	ベックアーロン, フリーマンアーサー, デイビスデニス, 井上和臣 and Masahito Tomotake : 改訂第2版パーソナリティ障害の認知療法全訳版, 岩崎学術出版社, Sep. 2011.
19.	Masahito Tomotake and 他 : パーソナリティ障害の認知療法, 岩崎学術出版社, Mar. 2011.
20.	Masahito Tomotake and Tetsuro Ohmori : Ⅴ章‐臨床各科で遭遇する幻覚妄想;泌尿・生殖器系, シナジー東京, 2011.
21.	Masahito Tomotake and 他 : 摂食障害の治療, Nakayama-Shoten Co., Ltd., Dec. 2010.
22.	Masahito Tomotake and 他 : 精神保健看護辞典, Ohmsha, Ltd., Apr. 2010.
23.	Masahito Tomotake : よくわかる精神科薬物ハンドブック．躁状態．, Shorinsha Inc., Dec. 2009.
24.	Masahito Tomotake : よくわかる精神科薬物ハンドブック．抑うつ状態．, Shorinsha Inc., Dec. 2009.
25.	Masahito Tomotake and 大森哲郎 : 精神科専門医のためのプラクティカル精神医学．気分障害．, Nakayama-Shoten Co., Ltd., Aug. 2009.
26.	Masahito Tomotake : チーム医療としての摂食障害診療．認知行動療法．, 株式会社診断と治療社, Feb. 2009.
27.	トレジャージャネット, スミスグレイン, クレインアナ, Masahito Tomotake, 中里道子 and 吉岡美佐緒 : -, 新水社, Oct. 2008.
28.	Masahito Tomotake : よくわかる精神科治療薬の考え方，使い方．摂食障害，睡眠障害, 株式会社中外医学社, Jun. 2008.
29.	Masahito Tomotake : よくわかる精神科治療薬の考え方，使い方．薬物療法と並行して行う心理社会的治療, 株式会社中外医学社, Jun. 2008.
30.	シュミットウルリケ, トレジャージャネット, Masahito Tomotake, 中里道子 and 吉岡美佐緒 : 過食症サバイバルキット, 金剛出版, Feb. 2007.
31.	Masahito Tomotake : EBM精神疾患の治療 2006∼2007．回復期のうつ状態に有効な薬剤はあるか．, 株式会社中外医学社, Feb. 2006.
32.	Masahito Tomotake : コメディカルのための専門基礎分野テキスト・精神医学．生理的障害および身体要因に関連した行動症候群, 株式会社中外医学社, Sep. 2004.
33.	石元康仁, 中土井芳弘, 谷口京子, 伊賀淳一, Masahito Tomotake and 他 : 第4回ムードディスオーダー・カンファランス．脳血管障害後のうつ状態についてのアンケート調査, Seiwa Shoten Co., Ltd., Tokyo, Aug. 2003.
34.	Masahito Tomotake and 大森哲郎 : 精神医学症候群Ⅱ．分裂病質人格障害, NIPPONRINSHOSHA Co.,Ltd., Aug. 2003.
35.	住谷さつき, 松下真美, 和田香代子, Masahito Tomotake and 他 : 強迫性障害の研究 (4)．TCIを用いたOCDとジストニアのパーソナリティーの比較, Seiwa Shoten Co., Ltd., May 2003.
36.	Masahito Tomotake and 他 : 精神障害をやさしく理解するQ&A 253, 日総研出版, Apr. 2003.
37.	Masahito Tomotake, 谷口隆英 and 大森哲郎 : 第3回ムードディスオーダー・カンファランス．顕著なひきこもりを呈した社会恐怖症患者の治療経験, Seiwa Shoten Co., Ltd., Nov. 2002.
38.	Masahito Tomotake, 中山浩 and 大森哲郎 : 強迫性障害の研究 (2)．非定型自閉症児のこだわり行動についての治療経験, Seiwa Shoten Co., Ltd., Mar. 2001.
39.	福西勇夫, 中山浩 and Masahito Tomotake : 臨床精神医学講座S6‐外傷後ストレス障害 (PTSD)．熱傷患者, Nakayama-Shoten Co., Ltd., Mar. 2000.

Academic Paper (Judged Full Paper):

1.	Shin-ichi Chiba, 小松龍矢, 中石真一路, 竹安敬子, Rie Tsutsumi, 豊内紳悟, 椋本琢磨 and Masahito Tomotake : Investigation for effects of nursing intervention using a directional speaker on clinical symptoms of dementia patients with hearing loss : First report., Shikoku Acta Medica, Vol.80, No.3,4, 113-120, 2024. (Keyword) directional speaker / dementia / cognitive function / BPSD / QOL (Link to Publication Site) ● Publication site (DOI): 10.57444/shikokuactamedica.80.3.4_113 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390864944467163264 ● Search Scopus @ Elsevier (DOI): 10.57444/shikokuactamedica.80.3.4_113 (DOI: 10.57444/shikokuactamedica.80.3.4_113, CiNii: 1390864944467163264)
2.	Shin-ichi Chiba, Masahito Tomotake and Rie Tsutsumi : Clarification of Psychiatric Nurses Intentions and Analysis Contents in Observing Schizophrenia Patient, The Journal of Medical Investigation : JMI, Vol.71, No.1,2, 54-61, 2024. (Tokushima University Institutional Repository) ● Metadata: 119160 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.71.54 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.71.54 (Tokushima University Institutional Repository: 119160, DOI: 10.2152/jmi.71.54)
3.	Tanioka Ryuichi, Kyoko Osaka, Hirokazu Ito, Zhao Yueren, Masahito Tomotake, Takase Kensaku and Tetsuya Tanioka : Examining Factors Associated with Dynapenia/Sarcopenia in Patients with Schizophrenia: A Pilot Case-Control Study, Healthcare, Vol.11, No.5, 684, 2023. (Keyword) dynapenia / sarcopenia / schizophrenia / basal metabolic rate / total muscle mass / skeletal muscle mass / body mass index (Tokushima University Institutional Repository) ● Metadata: 118730 (Link to Publication Site) ● Publication site (DOI): 10.3390/healthcare11050684 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.3390/healthcare11050684 (Tokushima University Institutional Repository: 118730, DOI: 10.3390/healthcare11050684)
4.	Rie Tsutsumi, Masahito Tomotake and Shin-ichi Chiba : A study on Relationship between Psychological Well-being and Menstrual -Associated Symptoms in Female University Students, Shikoku Acta Medica, Vol.78, No.5,6, 175-186, 2022. (Summary) Female-specific menstrual-associated symptoms are regarded as a factor to lower psychological well-being. The purpose of the current study was to clarify the relationship between psychologocal well-being and menstrual-associated symptoms. We conducted an anonymous survey using self-report questionnaires, in which the MOS 36-Item Short-Form Health Survey version1.2 (SF-36) and the Menstrual Distress Questionnaire (MDQ) were administered to 382 female university students in order to evaluate health-related quality of life and menstrual-associated symptoms respectively. Data from 311 subjects were analyzed to investigate the relationship between the two scales before, during and after menstruation and in strong and weak menstrual-associated symptoms groups. There were significant negative correlations between the SF-36 subscale `vitality' and the MDQ subscale `negative affect' before and during menstruation. In the strong menstrual-associated symptoms group, significant negative correlations were found between subscales of the SF-36 and the MDQ before, during and after menstruation, suggesting that psychological symptoms of menstrual-associated symptoms might influence their physical and psychological quality of life. We concludes that to examine coping methods in order to reduce psychological symptoms and to provide individualized education are necessary. (Keyword) psychological well-being / menstrual-associated symptom / female university student (Tokushima University Institutional Repository) ● Metadata: 117967 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520013962706095232 (Tokushima University Institutional Repository: 117967, CiNii: 1520013962706095232)
5.	Yoshimune Ishii, Masahito Tomotake, Shinichi Chiba, Rie Tsutsumi, Masatomo Aono and Koushiro Taguchi : Relationship between quality of life and clinical factors in inpatients with schizophrenia, The Journal of Medical Investigation : JMI, Vol.69, 80-85, 2022. (Summary) The purpose of this study was to clarify the relationship between quality of life (QOL) and clinical factors in inpatients with schizophrenia. Subjects were 50 hospitalized patients with schizophrenia. Their mean age was 56.48 (Standard Deviation=11.93) years. Japanese version of the schizophrenia Quality of Life Scale (JSQLS) and Subjective Well-being under Neuroleptic drug Treatment Short form, Japanese version (SWNS-J) were used to assess subjective QOL, and Mini Mental State Examination-Japanese was used to evaluate cognitive function. Japanese version of the Calgary Depression Scale for Schizophrenia (JCDSS), Brief Psychiatric Rating Scale, and Drug-Induced Extrapyramidal Symptoms Scale were used to assess depression severity, psychotic symptoms, and drug-induced extrapyramidal symptoms, respectively. Stepwise regression analyses were conducted to find factors influencing JSQLS and SWNS-J. JCDSS was a predictor of two scales of JSQLS, and JCDSS also predicted SWNS-J Total and it's two subscales. However, other clinical factors were not related to JSQLS and SWNS-J. The results indicate that treating depressive symptoms may lead to improvement of subjective QOL in inpatients with schizophrenia. J. Med. Invest. 69 : 80-85, February, 2022. (Keyword) Antipsychotic Agents / Humans / Inpatients / Middle Aged / Quality of Life / Schizophrenia / Schizophrenic Psychology (Tokushima University Institutional Repository) ● Metadata: 117016 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.69.80 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35466151 ● Summary page in Scopus @ Elsevier: 2-s2.0-85128802172 (Tokushima University Institutional Repository: 117016, DOI: 10.2152/jmi.69.80, PubMed: 35466151, Elsevier: Scopus)
6.	Ryuichi Tanioka, Hirokazu Ito, Kensaku Takase, Yoshihiro Kai, Kenichi Sugawara, Tetsuya Tanioka, Rozzano De Castro Locsin and Masahito Tomotake : Usefulness of 2D Video Analysis for Evalution of Shoulder Range of Motion during Upper Limb Exercise in Patients with Psychiatric Disorders, The Journal of Medical Investigation : JMI, Vol.69, No.1,2, 70-79, 2022. (Summary) Aging and its associated problems related to movement impacts the care of people with psychiatric disorders. This study sought to clarify the usefulness of 2D video analysis for evaluating shoulder range of motion (ROM) during upper limb exercises in patients with psychiatric disorders. Subjects (N=54) were patients with psychiatric disorders categorized as the following:having either a high or low activities of daily living (ADL) score using the Barthel Index;experiencing shoulder ROM limitation, and whether or not compensatory movements were exhibited. Compensatory movement was also considered in patients with Parkinsonism, cerebrovascular disease, and cognitive dysfunction. Shoulder joint ROM was measured using a goniometer and active ROM was captured using ImageJ. No significant difference between passive ROM measured by a goniometer and active ROM measured by ImageJ considering disease groups, ADL level, and shoulder ROM limitation was found. Factoring in compensatory movements, however, significant differences were found between passive and active ROM:existence compensatory movement group, left side (z=-2.30, p=0.02);nonexistence compensatory movement group, right side (z=-2.63, p<0.001). Image-evaluating devices help assess ROM in patients with psychiatric disorders, enhancing the development of physical rehabilitation programs to regain critical ADL, sustaining self-care capabilities. J. Med. Invest. 69 : 70-79, February, 2022. (Keyword) range of motion / 2D video analysis / compensatory movements / patients with psychiatric disorders / disuse syndrome (Tokushima University Institutional Repository) ● Metadata: 116938 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.69.70 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 35466149 ● Summary page in Scopus @ Elsevier: 2-s2.0-85128801602 (Tokushima University Institutional Repository: 116938, DOI: 10.2152/jmi.69.70, PubMed: 35466149, Elsevier: Scopus)
7.	Sachiko Kubo, Toshiyuki Yasui, Yukie Matsuura and Masahito Tomotake : Differences in Male Climacteric Symptoms by Aging Males Symptoms Scale and Coping Strategies with Aging among Rotating Night Shift Workers, Global Journal of Health Science, Vol.14, No.3, 1-11, 2022. (Link to Publication Site) ● Publication site (DOI): 10.5539/gjhs.v14n3p1 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.5539/gjhs.v14n3p1 (DOI: 10.5539/gjhs.v14n3p1)
8.	Shin-ichi Chiba, Masahito Tomotake, Rie Tsutsumi, Tatsuya Komatsu and Takuma Mukumoto : Characteristics of psychiatric nurses observation techniques for psychopathological symptoms, The Journal of Medical Investigation : JMI, Vol.68, No.3,4, 271-275, 2021. (Summary) The purpose of this study was to clarify characteristics of psychiatric nurses' observation techniques for psychopathological symptoms. The subjects were 21 psychiatric nurses and 20 nursing students who had finished their practicum in psychiatric nursing. Using a non-contact eye-tracking analysis system, we compared quantitatively their radial motion while they were observing psychopathological symptoms of a schizophrenia simulation patient. The radial motion of them was recorded while they were observing a video of a simulated patient presenting psychopathological symptoms, and the recording was analyzed by the eye-tracking system. The investigator set the important observation areas and determined the sum of the fixation time and the number of fixations in the areas. Differences between psychiatric nurses and nursing students were tested using the Mann-Whitney U-test. The results revealed a significant difference in observation of the upper limbs area with a median of 7147.90 msec for nurses group and a median of 2447.54 msec for students group (U = 98.00, p = 0.01). The finding suggests that nurses tend to pay more attention to patient's upper limbs to be cautious about possible violence and to find agitation caused by psychopathological symptoms, extrapyramidal adverse effects, and scars caused by self-mutilation. J. Med. Invest. 68 : 271-275, August, 2021. (Keyword) Humans / Mental Disorders / Nurses / Psychiatric Nursing (Tokushima University Institutional Repository) ● Metadata: 116379 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.68.271 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34759143 ● Summary page in Scopus @ Elsevier: 2-s2.0-85119275269 (Tokushima University Institutional Repository: 116379, DOI: 10.2152/jmi.68.271, PubMed: 34759143, Elsevier: Scopus)
9.	Tanioka Ryuichi, Kazuyuki Matsumoto, Sugawara Kenichi, Takase Kensaku, Kai Yoshihiro, Masahito Tomotake, Tetsuya Tanioka and Rozzano De Castro Locsin : Practical issues in Developing Natural Language Processing Applications for Healthcare Robot Motivation of Older Persons Physical Rehabilitation, International Journal of Advanced Intelligence (IJAI), Vol.12, No.1, 83-90, 2021. (Keyword) natural language processing / communication and rehabilitation humanoid robots / data applications / clinical evaluation / interdisciplinary research / older person
10.	Sachiko Kubo, Toshiyuki Yasui, Reiko Okahisa, Yukie Matsuura and Masahito Tomotake : Differences in Male Climacteric Symptoms and Lifestyle Depending on the Duration of Working among Rotating Night Shift Workers, Health, Vol.12, 1598-1609, 2020. (Tokushima University Institutional Repository) ● Metadata: 115934 (Link to Publication Site) ● Publication site (DOI): 10.4236/health.2020.1212116 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.4236/health.2020.1212116 (Tokushima University Institutional Repository: 115934, DOI: 10.4236/health.2020.1212116)
11.	Takeo Tominaga, Masahito Tomotake, Tomoya Takeda, Yoshinori Ueoka, Tsunehiko Tanaka, Shinya Watanabe, Naomi Kameoka, Masahito Nakataki, Shusuke Numata, Yumiko Izaki, Satsuki Sumitani, Hiroko Kubo, Yasuhiro Kaneda and Tetsuro Ohmori : Predictors of life skills in people with schizophrenia, The Journal of Medical Investigation : JMI, Vol.67, No.1,2, 75-82, 2020. (Summary) Objective : The purpose of the present study is to examine clinical factors related to life skills in people with schizophrenia. Method : The participants were 51 stabilized outpatients with schizophrenia. Their mean age was 38.91 (SD = 10.73) years. Life skills were assessed using the Life skills profile (LSP). Cognitive function was evaluated with the Measurement and Treatment Research to Improve Cognition in Schizophrenia Consensus Cognitive Battery (MCCB). Clinical symptoms were assessed using the Positive and Negative Syndrome scale (PANSS), the Calgary Depression Scale for Schizophrenia (CDSS) and the Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS). Results : Cognitive function was not correlated with the LSP scores at all. Among clinical symptoms, scores of the PANSS positive and negative syndrome scales, the CDSS, and the DIEPSS had negative correlations with the LSP total score and the subscales. Stepwise regression analyses showed that the CDSS and PANSS negative syndrome scale scores were independent predictors of the LSP total score and two of the subscales. Conclusions : These results indicate that cognitive function is not associated with life skills but clinical symptoms such as depressive and negative symptoms have considerable impacts on life skills in people with schizophrenia. J. Med. Invest. 67 : 75-82, February, 2020. (Tokushima University Institutional Repository) ● Metadata: 114756 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.67.75 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 32378622 ● Summary page in Scopus @ Elsevier: 2-s2.0-85084203721 (Tokushima University Institutional Repository: 114756, DOI: 10.2152/jmi.67.75, PubMed: 32378622, Elsevier: Scopus)
12.	Arisa Kurokawa, Yuko Yasuhara, Hirokazu Ito, Tetsuya Tanioka, Masahito Tomotake, 趙岳人, 岩田修一, Mutsuko Kataoka, Hiroko Sugimoto and 三船和史 : Relation between oral condition and internal use condition of psychotropic drugs of patients with chronic schizophrenia during hospitalization : Cross-sectional survey at a psychiatric hospital with dentistry, Rinsyo Seisin Yakuri, Vol.22, No.8, 845-853, 2019. (Keyword) oral health conditions / hospitalized chronic-phase patients with schizophrenia / chlorpromazine-equivalent dose / biperiden-equivalent dose (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1522543655949725952 (CiNii: 1522543655949725952)
13.	Sachiko Kubo, Toshiyuki Yasui, Yukie Matsuura and Masahito Tomotake : Differences in male climacteric symptoms with aging among rotating night shift workers, The Aging Male, Vol.Aug 9, 1-9, 2019. (Summary) The aim of this study was to clarify the actual status of male climacteric symptoms in rotating night shift workers and how to cope with the symptoms. We planned a self-administered questionnaire survey in male rotating night shift workers. Male climacteric symptoms were evaluated by using the Aging Males' Symptoms (AMS) scale. Of 1891 questionnaires that were sent, 1561 were collected. There were significant differences in total AMS scores among the age groups. In all age groups, there were high proportions of men with increased need for sleep and often feeling tired (64.9%) and decrease in muscular strength (60.7%). There were significant differences in AMS scores for somatic symptoms between men in their 20 s and those in their 40 s or 50 s and between men in their 30 s and those in their 50 s and in AMS scores for sexual symptoms between men in their 20 s and those in their 30 s, 40 s, 50 s or 60 s, between men in their 30 s and those in their 40 s, 50 s or 60 s and between men in their 40 s and those in their 50 s or 60 s. Significant age-dependent differences are found in somatic symptoms and sexual symptoms in rotating night shift workers. (Link to Publication Site) ● Publication site (DOI): 10.1080/13685538.2019.1650264 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 31397630 ● Summary page in Scopus @ Elsevier: 2-s2.0-85070807214 (DOI: 10.1080/13685538.2019.1650264, PubMed: 31397630, Elsevier: Scopus)
14.	Chikako Kane, Masahito Tomotake, Hamatani Sayo, Shin-ichi Chiba, Naomi Kameoka, Shinya Watanabe, Masahito Nakataki, Shusuke Numata and Tetsuro Ohmori : Clinical factors influencing resilience in patients with anorexia nervosa, Neuropsychiatric Disease and Treatment, Vol.15, 391-395, 2019. (Summary) This study was to elucidate clinical factors influencing resilience in anorexia nervosa (AN) patients. Twenty female patients with AN (median age =30.0 years, quartile deviation =6.8) and 40 female healthy controls (HCs) (median age =30.0 years, quartile deviation =8.6) participated in the present study. Resilience was assessed with the Connor- Davidson resilience scale (CD-RISC). Clinical symptoms were evaluated with the structured interview guide for the Hamilton depression rating scale (SIGH-D) and the eating disorder inventory-2 (EDI-2). Scores of the CD-RISC in the AN group were lower than those in the HC group, and the SIGH-D score in the AN group was higher than that in the HC group. Scores of interoceptive confusion, interpersonal difficulty and negative self-image subscales of the EDI-2 negatively correlated with the CD-RISC score. Moreover, stepwise regression analysis showed that negative self-image score was an independent predictor of the CD-RISC score. These results suggest that among these clinical factors including psychopathologies, self-dissatisfaction and feeling of being rejected by others are the most important influencing factors on an AN patients' resilience. (Tokushima University Institutional Repository) ● Metadata: 115649 (Link to Publication Site) ● Publication site (DOI): 10.2147/NDT.S190725 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 30787613 ● Summary page in Scopus @ Elsevier: 2-s2.0-85062653550 (Tokushima University Institutional Repository: 115649, DOI: 10.2147/NDT.S190725, PubMed: 30787613, Elsevier: Scopus)
15.	Takeo Tominaga, Masahito Tomotake, Tomoya Takeda, Yoshinori Ueoka, Tsunehiko Tanaka, Shinya Watanabe, Naomi Kameoka, Masahito Nakataki, Shusuke Numata, Yumiko Izaki, Satsuki Sumitani, hiroko Kubo, Yasuhiro Kaneda and Tetsuro Ohmori : Relationship between social and cognitive functions in people with schizophrenia, Neuropsychiatric Disease and Treatment, Vol.14, 2215-2224, 2018. (Summary) The purpose of the present study was to examine clinical factors related to social function in people with schizophrenia. The participants were 55 stabilized outpatients with schizophrenia. Their mean age was 39.36 (SD =10.65) years. Social function was assessed using the Quality of Life Scale (QLS). Cognitive function was evaluated with the Measurement and Treatment Research to Improve Cognition in Schizophrenia Consensus Cognitive Battery (MCCB). Clinical symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS), the Calgary Depression Scale for Schizophrenia, and the Drug-Induced Extrapyramidal Symptoms Scale. Neither the MCCB cognitive domain score nor composite score was correlated with the QLS scores. However, of the 10 MCCB subtests, the Trail Making Test Part A and the Brief Assessment of Cognition in Schizophrenia-Symbol Coding (BACS-SC) scores were positively correlated with the QLS scores. Among clinical variables, especially the PANSS negative syndrome scale score had a strong negative correlation with the QLS scores. Stepwise regression analyses showed that the PANSS negative syndrome scale score was an independent predictor of the QLS scores, and although the BACS-SC score predicted the QLS common objects and activities subscale score, the association was not so strong compared to the PANSS negative syndrome scale score. These results indicate that speed of processing evaluated by BACS-SC could predict some aspect of social function but negative symptoms have a much stronger impact on global social function in people with schizophrenia. (Tokushima University Institutional Repository) ● Metadata: 114525 (Link to Publication Site) ● Publication site (DOI): 10.2147/NDT.S171207 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 30214211 ● Summary page in Scopus @ Elsevier: 2-s2.0-85057540520 (Tokushima University Institutional Repository: 114525, DOI: 10.2147/NDT.S171207, PubMed: 30214211, Elsevier: Scopus)
16.	Chikako Kane, Masahito Tomotake, Sayo Hamatani, Shin-ichi Chiba and Tetsuro Ohmori : Clinical factors influencing quality of life in anorexia nervosa patients, Open Journal of Psychiatry, Vol.8, 50-60, 2018. (Keyword) Anorexia Nervosa / quality of life (Tokushima University Institutional Repository) ● Metadata: 111628 (Link to Publication Site) ● Publication site (DOI): 10.4236/ojpsych.2018.81004 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.4236/ojpsych.2018.81004 (Tokushima University Institutional Repository: 111628, DOI: 10.4236/ojpsych.2018.81004)
17.	Shin-ichi Chiba, Masahito Tomotake, 青野将知, 利光秀文 and Tetsuro Ohmori : Functional Independence Measureを用いて評価した統合失調症入院患者の基本的な社会生活機能と臨床諸要因との関連, Shikoku Acta Medica, Vol.73, No.5,6, 283-288, 2017. (Summary) Objective : The aim of the present study is to explore clinical factors associated with basic ability of social life in schizophrenia inpatients. Methods : The subjects were 50 inpatients with schizophrenia (DSM‐IV). Their mean age was 53.08 (SD＝12.08) years. Social life functioning was evaluated using the Functional Independence Measure (FIM). Cognitive function was assessed with the Brief Assessment of Cognition in Schizophrenia (BACS) and clinical symptoms with the Positive and Negative Syndrome Scale (PANSS), the Calgary Depression Scale for Schizophrenia (CDSS) and the Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS). Results : FIM motor subscale score showed a significant correlation with the DIEPSS score (r＝0.33, p<0.05). The FIM cognitive subscale score showed significant correlations with the PANSS positive syndrome score (r＝-0.30, p<0.05), the PANSS negative syndrome score (r＝-0.37, p<0.01) and the DIEPSS score (r＝-0.40, p<0.01). Conclusion : These results suggest that positive and negative symptoms and drug-induced extrapyramidal symptoms are much more important factors related to lowered basic ability of social life of schizophrenia inpatients than cognitive function. (Keyword) 統合失調症 / 社会生活機能 / 臨床要因 / 認知機能 (Tokushima University Institutional Repository) ● Metadata: 112054 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050583647830181376 (Tokushima University Institutional Repository: 112054, CiNii: 1050583647830181376)
18.	Sayo Hamatani, Masahito Tomotake, Tomoya Takeda, Naomi Kameoka, Masashi Kawabata, Hiroko Kubo, Masashi Ohta, Yukio Tada, Yukiko Tomioka, Shinya Watanabe, Masatoshi Inoshita, Makoto Kinoshita and Tetsuro Ohmori : Impaired central coherence in patients with anorexia nervosa, Psychiatry Research, Vol.259, 77-80, 2017. (Summary) The purpose of this study was to investigate the characteristics of central coherence in patients with anorexia nervosa (AN). 22 female patients with AN (median age = 31.50 (QD = 8.13) years) and 33 female healthy controls (HC) (median age = 28.00 (QD = 8.50) years) participated in the study. Their central coherence was assessed with the Rey Complex Figure Task (RCFT). Clinical symptoms were evaluated with the Beck Depression Inventory-II and the State-Trait Anxiety Inventory-Form JYZ. The results showed that AN patients' Central Coherence Index and accuracy scores in copy, 3-min delayed recall and 30-min delayed recall tasks of the RCFT were significantly lower than those of HC. Moreover, the significant differences in Central Coherence Index score in copy task and accuracy scores in 3-min delayed recall and 30-min delayed recall tasks remained when the effects of depression, anxiety and starvation were eliminated statistically. These findings may explain some characteristics of AN patients such as focusing on local rather than global picture in their perception of body or life. (Link to Publication Site) ● Publication site (DOI): 10.1016/j.psychres.2017.09.086 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 29031167 ● Summary page in Scopus @ Elsevier: 2-s2.0-85031017522 (DOI: 10.1016/j.psychres.2017.09.086, PubMed: 29031167, Elsevier: Scopus)
19.	Sayo Hamatani, Masahito Tomotake, Tomoya Takeda, Naomi Kameoka, Masashi Kawabata, Hiroko Kubo, Y Tada, Yukiko Tomioka, Shinya Watanabe, Masatoshi Inoshita, Makoto Kinoshita, Masashi Ohta and Tetsuro Ohmori : Influence of cognitive function on quality of life in anorexia nervosa patients, Psychiatry and Clinical Neurosciences, Vol.71, No.5, 328-335, 2017. (Summary) The purpose of this study was to elucidate determinants of quality of life (QOL) in anorexia nervosa (AN) patients. Twenty-one female patients with AN participated in the study. QOL was assessed with the 36-Item Short Form Health Survey (SF-36), and cognitive function was evaluated using the Wisconsin Card Sorting Test Keio version, the Rey Complex Figure Test, and the Social Cognition Screening Questionnaire. Clinical symptoms were evaluated with the Beck Depression Inventory-II, the State-Trait Anxiety Inventory-Form JYZ (STAI-JYZ), and the Maudsley Obsessive Compulsive Inventory. The Difficulty Maintaining Set score of the Wisconsin Card Sorting Test Keio version was negatively correlated to the SF-36 Physical Component Summary. Scores of the Beck Depression Inventory-II and the STAI-JYZ State and Trait were negatively correlated to the SF-36 Mental Component Summary (MCS), and the Central Coherence Index 30-min Delayed Recall score of the Rey Complex Figure Test was positively correlated with the MCS. Stepwise regression analysis showed that the Difficulty Maintaining Set score was an independent predictor of the Physical Component Summary and scores for Central Coherence Index 30-min Delayed Recall and the STAI-JYZ Trait-predicted MCS. These results suggest that not only trait anxiety but also poor central coherence and impaired ability to maintain new rule worsen AN patients' QOL. (Link to Publication Site) ● Publication site (DOI): 10.1111/pcn.12491 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 27973723 ● Search Scopus @ Elsevier (PMID): 27973723 ● Search Scopus @ Elsevier (DOI): 10.1111/pcn.12491 (DOI: 10.1111/pcn.12491, PubMed: 27973723)
20.	武田知也, Sayo Hamatani, 田丸麻衣, Motohiro Sakai, Masahito Tomotake and Tetsuro Ohmori : 認知行動療法的介入が有効であった心因性難聴の事例, Japanese Journal of Child and Adolescent Psychiatry, Vol.58, No.2, 254-260, 2017. (Link to Publication Site) ● Publication site (DOI): 10.20615/jscap.58.2_254 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390282763134730880 ● Search Scopus @ Elsevier (DOI): 10.20615/jscap.58.2_254 (DOI: 10.20615/jscap.58.2_254, CiNii: 1390282763134730880)
21.	Sayo Hamatani, Masahito Tomotake, Tomoya Takeda, Naomi Kameoka, Masashi Kawabata, Hiroko Kubo, Yukio Tada, Yukiko Tomioka, Shinya Watanabe and Tetsuro Ohmori : Impaired social cognition in anorexia nervosa patients, Neuropsychiatric Disease and Treatment, Vol.12, 2527-2531, 2016. (Summary) The purpose of this study was to investigate the characteristics of social cognition in patients with anorexia nervosa (AN). Eighteen female patients with AN (mean age =35.4±8.6 years) and 18 female healthy controls (HC) (mean age =32.8±9.4 years) participated in the study. Their social cognition was assessed with the Social Cognition Screening Questionnaire (SCSQ). The results showed that total score of the SCSQ and scores of theory of mind and metacognition were significantly lower in AN group than those in HC group. Moreover, significant differences in theory of mind, metacognition, and total score of the SCSQ remained when the effects of depression, anxiety, and starvation were eliminated statistically. These results suggest that patients with AN may have difficulty inferring other people's intention and also monitoring and evaluating their own cognitive activities. Therefore, these features may explain some aspects of the pathology of AN. (Tokushima University Institutional Repository) ● Metadata: 110040 (Link to Publication Site) ● Publication site (DOI): 10.2147/NDT.S116521 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 27785029 ● Summary page in Scopus @ Elsevier: 2-s2.0-84991583740 (Tokushima University Institutional Repository: 110040, DOI: 10.2147/NDT.S116521, PubMed: 27785029, Elsevier: Scopus)
22.	Hirokazu Ito, Misao Miyagawa, Kazuhiro Ozawa, Tetsuya Tanioka, Yuko Yasuhara, Mutsuko Kataoka, Beth King, Masahito Tomotake, Yumi Kuwamura and Rozzano De Castro Locsin : Prioritizing Patient Assessment Data (PAD) Using the Japanese Psychiatric Nursing Assessment Classification System (PsyNACS)©, Open Journal of Psychiatry, Vol.6, No.3, 218-227, 2016. (Keyword) PsyNACS© / Nursing Database / Priority Nursing Assessment Items / Unit Function / Psychiatric Hospital (Link to Publication Site) ● Publication site (DOI): 10.4236/ojpsych.2016.63027 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.4236/ojpsych.2016.63027 (DOI: 10.4236/ojpsych.2016.63027)
23.	Shin-ichi Chiba, Masahito Tomotake, Masatomo Aono, Hidefumi Toshimitsu and Tetsuro Ohmori : Clinical correlates associated with basic ability of social life in schizophrenia inpa-tients, Open Journal of Psychiatry, Vol.6, No.1, 71-75, 2016. (Keyword) schizophrenia / inpatient / social life functioning / cognitive function (Tokushima University Institutional Repository) ● Metadata: 109982 (Link to Publication Site) ● Publication site (DOI): 10.4236/ojpsych.2016.61008 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.4236/ojpsych.2016.61008 (Tokushima University Institutional Repository: 109982, DOI: 10.4236/ojpsych.2016.61008)
24.	Tomoya Takeda, Masahito Tomotake, Yoshinori Ueoka, Tsunehiko Tanaka, Takeo Tominaga, Yasuhiro Kaneda and Tetsuro Ohmori : Relationship between cognitive function and employment in Japanese schizophrenia patients, Open Journal of Psychiatry, Vol.6, 65-70, 2016. (Link to Publication Site) ● Publication site (DOI): 10.4236/ojpsych.2016.61007 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.4236/ojpsych.2016.61007 (DOI: 10.4236/ojpsych.2016.61007)
25.	Naomi Kameoka, Junichi Iga, Mai Tamaru, Takeo Tominaga, Hiroko Kubo, Shinya Watanabe, Satsuki Sumitani, Masahito Tomotake and Tetsuro Ohmori : Risk factors for refeeding hypophosphatemia in Japanese inpatients with anorexia nervosa., The International Journal of Eating Disorders, Vol.49, No.4, 402-406, 2016. (Summary) Refeeding in patients with anorexia nervosa (AN) is associated with a risk of refeeding syndrome, which is a disruption in metabolism with a variety of features including hypophosphatemia. We evaluated the risk factors for refeeding hypophosphatemia (RH) during nutritional replenishment in Japanese patients with AN. We retrospectively examined clinical data for 99 female inpatients (mean age 30.9 ± 10.7 years; range, 9 - 56 years). RH (phosphate < 2.3 mg/dL) occurred within 4.8 ± 3.7 days of hospital admission and was still observed at 28 days after admission in 21 of the 99 cases (21.2%). Oral or intravenous phosphate was given to some patients to treat or prevent RH. Patients with RH had a significantly lower body mass index, were older, and had higher blood urea nitrogen than those without RH. Severe complications associated with RH were recorded in only one patient who showed convulsions and disturbed consciousness at Day 3 when her serum phosphate level was 1.6 mg/dL. The significant risk factors for RH that we identified were lower body mass index, older age, and higher blood urea nitrogen at admission. No significant difference in total energy intake was seen between the RH and no RH groups, suggesting that RH may not be entirely correlated with energy intake. Precisely predicting and preventing RH is difficult, even in patients with AN who are given phosphate for prophylaxis. Thus, serum phosphate levels should be monitored for more than 5 days after admission. (Keyword) Adolescent / Adult / Anorexia Nervosa / Child / Energy Intake / Female / Hospitalization / Humans / Hypophosphatemia / Japan / Middle Aged / Refeeding Syndrome / Retrospective Studies / Risk Factors / Young Adult (Tokushima University Institutional Repository) ● Metadata: 114060 (Link to Publication Site) ● Publication site (DOI): 10.1002/eat.22472 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 26446402 ● Search Scopus @ Elsevier (PMID): 26446402 ● Search Scopus @ Elsevier (DOI): 10.1002/eat.22472 (Tokushima University Institutional Repository: 114060, DOI: 10.1002/eat.22472, PubMed: 26446402)
26.	Hirokazu Ito, Misao Miyagawa, Kazuhiro Ozawa, Tetsuya Tanioka, Yuko Yasuhara, Mutsuko Kataoka, Beth King, Masahito Tomotake and Rozzano De Castro Locsin : The Development of the Japanese Psychiatric Nursing Assessment Classification System (PsyNACS©), Open Journal of Psychiatry, Vol.6, No.1, 20-33, 2015. (Keyword) PsyNACS / psychiatric nursing / Patient Assessment Data / Psychiatric Hospital (Tokushima University Institutional Repository) ● Metadata: 109700 (Link to Publication Site) ● Publication site (DOI): 10.4236/ojpsych.2016.61003 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.4236/ojpsych.2016.61003 (Tokushima University Institutional Repository: 109700, DOI: 10.4236/ojpsych.2016.61003)
27.	Atsuko Aki and Masahito Tomotake : Changes of levels of depression and qaulity of life after short-term cognitive behavioral educational program for adolescent students in health class, The Journal of Medical Investigation : JMI, Vol.62, No.3,4, 204-208, 2015. (Summary) The purpose of the present study was to evaluate the changes of levels of depression and quality of life in adolescent students after receiving short-term cognitive behavioral educational program in health class for stress management. Subjects were 176 middle school students aged 12 to 14 years. They completed the Depression Self-Rating Scale for Children (DSRS-C) and the Revised Children Quality of Life Questionnaire (Kiddo-KINDL(R)) before, after and 6-months after the program. The three-session program consisted of psychoeducation and learning skills of cognitive restructuring and problem solving. The total scores of the DSRS-C and the Kiddo-KINDL(R) in all subjects did not significantly change after the completion of program. However, as for the high risk group (score of the DSRS-C≥16), significant improvement in the two scales was found after the program. Especially, depression level in the high risk group significantly decreased and the improvement was maintained 6-months later. These results suggest that this type of approach may be effective for adolescents with high risk of depression in terms of improving not only depressive symptom but also quality of life. J. Med. Invest. 62: 204-208, August, 2015. (Tokushima University Institutional Repository) ● Metadata: 111280 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.62.204 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 26399349 ● Summary page in Scopus @ Elsevier: 2-s2.0-84942027541 (Tokushima University Institutional Repository: 111280, DOI: 10.2152/jmi.62.204, PubMed: 26399349, Elsevier: Scopus)
28.	Yueren Zhao, Yuko Yasuhara, Tetsuya Tanioka, Sakiko Sakamaki, Masahito Tomotake, Beth King, Rozzano De Castro Locsin and Nakao Iwata : The Effect of a Psycho-Educational Program on Psychiatric Symptoms, Drug Attitude and Treatment Satisfaction of Patients with Schizophrenia, Open Journal of Psychiatry, Vol.5, 229-237, 2015. (Keyword) schizophrenia / Long-Acting Injection / educational psychology / COMPASS (Comprehensive Psycho-Educational Approach and Scheme Set) / Adherence / Satisfaction Level (Link to Publication Site) ● Publication site (DOI): 10.4236/ojpsych.2015.53027 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.4236/ojpsych.2015.53027 (DOI: 10.4236/ojpsych.2015.53027)
29.	Akira Nishi, Shusuke Numata, Atsushi Tajima, Makoto Kinoshita, K Kikuchi, S Shimodera, Masahito Tomotake, K Ohi, R Hashimoto, Issei Imoto, M Takeda and Tetsuro Ohmori : Meta-analyses of Blood Homocysteine Levels for Gender and Genetic Association Studies of the MTHFR C677T Polymorphism in Schizophrenia., Schizophrenia Bulletin, Vol.40, No.5, 1154-1163, 2014. (Summary) Previous studies suggest that elevated blood homocysteine levels and the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism are risk factors for schizophrenia. However, the effects of gender and MTHFR C677T genotypes on blood homocysteine levels in schizophrenia have not been consistent. We first investigated whether plasma total homocysteine levels were higher in patients with schizophrenia than in controls with stratification by gender and by the MTHFR C677T genotypes in a large cohort (N = 1379). Second, we conducted a meta-analysis of association studies between blood homocysteine levels and schizophrenia separately by gender (N = 4714). Third, we performed a case-control association study between the MTHFR C677T polymorphism and schizophrenia (N = 4998) and conducted a meta-analysis of genetic association studies based on Japanese subjects (N = 10 378). Finally, we assessed the effect of plasma total homocysteine levels on schizophrenia by a mendelian randomization approach. The ANCOVA after adjustment for age demonstrated a significant effect of diagnosis on the plasma total homocysteine levels in all strata, and the subsequent meta-analysis for gender demonstrated elevated blood homocysteine levels in both male and female patients with schizophrenia although antipsychotic medication might influence the outcome. The meta-analysis of the Japanese genetic association studies demonstrated a significant association between the MTHFR C677T polymorphism and schizophrenia. The mendelian randomization analysis in the Japanese populations yielded an OR of 1.15 for schizophrenia per 1-SD increase in plasma total homocysteine. Our study suggests that increased plasma total homocysteine levels may be associated with an increased risk of schizophrenia. (Tokushima University Institutional Repository) ● Metadata: 109373 (Link to Publication Site) ● Publication site (DOI): 10.1093/schbul/sbt154 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 24535549 ● Summary page in Scopus @ Elsevier: 2-s2.0-84907348082 (Tokushima University Institutional Repository: 109373, DOI: 10.1093/schbul/sbt154, PubMed: 24535549, Elsevier: Scopus)
30.	Mika Kataoka, Kazuhiro Ozawa, Masahito Tomotake, Tetsuya Tanioka and Beth King : Occupational stress and its related factors among university teachers in Japan, Health, Vol.6, No.5, 299-305, 2014. (Link to Publication Site) ● Publication site (DOI): 10.4236/health.2014.65043 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.4236/health.2014.65043 (DOI: 10.4236/health.2014.65043)
31.	Miki Satoh, Yuko Yasuhara, Tetsuya Tanioka, Yukie Iwasa, Masafumi Miyake, Toshiyuki Yasui, Masahito Tomotake, Haruo Kobayashi and Rozzano De Castro Locsin : Measuring quality of sleep and autonomic nervous function in healthy Japanese women, Neuropsychiatric Disease and Treatment, Vol.2014, No.10, 89-96, 2014. (Keyword) Pittsburgh Sleep Quality Index / actigraph / autonomic nervous system activity / heart rate variability / screening method (Tokushima University Institutional Repository) ● Metadata: 106066 (Link to Publication Site) ● Publication site (DOI): 10.2147/NDT.S56827 (Link to Search Site for Scientific Articles) ● Summary page in Scopus @ Elsevier: 2-s2.0-84892742608 (Tokushima University Institutional Repository: 106066, DOI: 10.2147/NDT.S56827, Elsevier: Scopus)
32.	Tetsuya Tanioka, Sakiko Sakamaki, Yuko Yasuhara, Masahito Tomotake, Kensaku Takase, Chie Watari, Kouichi Makiguchi, Rozzano De Castro Locsin, Kazushi Motoki and Tatsuya Inui : Optimal needle insertion length for intramuscular injection of risperidone long-acting injectable (RLAI), Health, Vol.5, No.12, 1939-1945, 2013. (Keyword) Risperidone Long-Acting Injectable / Gluteal Muscle / Intramuscular Injection / Optimal Needle Insertion Length / Body Muss Index (Link to Publication Site) ● Publication site (DOI): 10.4236/health.2013.512262 (Link to Search Site for Scientific Articles) ● Search Scopus @ Elsevier (DOI): 10.4236/health.2013.512262 (DOI: 10.4236/health.2013.512262)
33.	Tetsuya Tanioka, Shin-ichi Chiba, Chiemi Onishi, Mika Kataoka, Ai Kawamura, Masahito Tomotake, Christine L. Williams, Yuko Yasuhara and Kazushi Mifune : Factors associated with discharge of long-term inpatients with schizophrenia in Japan: a retrospective study, Issues in Mental Health Nursing, Vol.34, No.4, 256-264, 2013. (Summary) Deinstitutionalization for people with mental disorders has only begun to be implemented in Japan. The purpose of this retrospective study was to examine factors associated with discharge for long-term patients with schizophrenia. Seventy patients were judged capable of discharge with psychiatric rehabilitation (special staff service). As a result of rehabilitation efforts, 37 patients were discharged and 33 patients remained in the hospital. Significant differences were found in age, level of family agreement about patient's disability, and length of the special staff service. These factors might be important to predict patients' potential for discharge. (Keyword) Adult / Age Factors / Aged / Deinstitutionalization / Humans / Japan / Length of Stay / Middle Aged / Patient Discharge / Retrospective Studies / Schizophrenia (Link to Publication Site) ● Publication site (DOI): 10.3109/01612840.2012.742602 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 23566188 ● Summary page in Scopus @ Elsevier: 2-s2.0-84876068472 (DOI: 10.3109/01612840.2012.742602, PubMed: 23566188, Elsevier: Scopus)
34.	Tsunehiko Tanaka, Masahito Tomotake, Yoshinori Ueoka, Yasuhiro Kaneda, Kyoko Taniguchi, Masahito Nakataki, Shusuke Numata, Shinya Tayoshi, Ken Yamauchi, Satsuki Sumitani, Takashi Ohmori, Shu-ichi Ueno and Tetsuro Ohmori : Clinical correlates associated with cognitive dysfunction in people with schizophrenia., Psychiatry and Clinical Neurosciences, Vol.66, No.6, 491-498, 2012. (Link to Publication Site) ● Publication site (DOI): 10.1111/j.1440-1819.2012.02390.x (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 23066766 ● Search Scopus @ Elsevier (PMID): 23066766 ● Search Scopus @ Elsevier (DOI): 10.1111/j.1440-1819.2012.02390.x (DOI: 10.1111/j.1440-1819.2012.02390.x, PubMed: 23066766)
35.	Tetsuya Tanioka, Syoko Fuji, Mika Kataoka, Beth King, Masahito Tomotake, Yuko Yasuhara, Rozzano Locsin, Keiko Sekido and Kazushi Mifune : Retrospective study of Japanese patients with schizophrenia treated with aripiprazole., ISRN Nursing, Vol.2012, 454898, 2012. (Summary) Aim. The purpose of this retrospective study was to evaluate changes in clinical indicators which influence the quality of life (QOL) of patients with schizophrenia treated by antipsychotic therapy before and after switching to aripiprazole. Methods. A retrospective chart review of 27 patients diagnosed with schizophrenia and who were switched from one antipsychotic to aripiprazole was performed. Clinical indicators about the daily dosage of antipsychotics and antiparkinsonian drugs, psychiatric condition, and glucose/lipid metabolism, clinical evaluation by nursing observation were used to measure the responsiveness of subjects to aripiprazole. Results. Of the 27 subjects, 14 responded to the switch to aripiprazole with significant improvement of the Brief Psychiatric Rating Scale (BPRS) score (P = 0.04), significant decrease in dosage of antipsychotics in 71% of patients (P = 0.03), and tendency toward reduction in dosage of antiparkinsonian drugs (P = 0.07) and body mass index (BMI) (P = 0.06). However, 8 of 27 subjects had a significant increase in lipid levels after switching to aripiprazole (P = 0.01). Conclusion. QOL for subjects who responded to the switch to aripiprazole improved as indicated by lower doses of antipsychotic and antiparkinson medications, improvement in BPRS score, and a decrease in BMI. Results indicate little influence on patient's QOL. (Link to Publication Site) ● Publication site (DOI): 10.5402/2012/454898 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 22970386 ● Search Scopus @ Elsevier (PMID): 22970386 ● Search Scopus @ Elsevier (DOI): 10.5402/2012/454898 (DOI: 10.5402/2012/454898, PubMed: 22970386)
36.	Naomi Kameoka, Yoshihiro Nakadoi, Tetsuro Ohmori and Masahito Tomotake : 摂食障害患者にみられるRefeeding syndromeについて, Shikoku Acta Medica, Vol.68, No.1-2, 87, 2012.
37.	Masahito Tomotake : Quality of life and its predictors in people with schizophrenia., The Journal of Medical Investigation : JMI, Vol.58, No.3-4, 167-174, 2011. (Summary) The author reviewed measurement of quality of life (QOL) of schizophrenia patients and the clinical factors related to their QOL. As schizophrenia patients were thought to be unable to assess their own QOL because of their cognitive impairment, objective QOL measures had been frequently used. However, nowadays, there is general agreement that symptomatically stabilized patients could assess their QOL by themselves. Therefore, researchers gradually have become interested in subjective QOL measure. Although most researchers often evaluate schizophrenia patients' QOL using only subjective or objective QOL measure, considering the fact that there is a discrepancy between the two types of measures, it is recommended to use both of them as complementary measures. As for clinical factors related to lowered QOL, several studies reported that depressive symptom was most associated with lowered subjective QOL, negative symptom was strongly related to lowered objective one and poor life skill was associated with both. Moreover, several studies found that cognitive dysfunctions in some cognitive domains were related to lowered objective QOL but the effects of them were much smaller than those of negative symptoms. It is suggested that improving depressive and negative symptoms and life skills may contribute to enhancement of QOL of schizophrenia patients. (Tokushima University Institutional Repository) ● Metadata: 83107 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.58.167 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21921416 ● Search Scopus @ Elsevier (PMID): 21921416 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.58.167 (Tokushima University Institutional Repository: 83107, DOI: 10.2152/jmi.58.167, PubMed: 21921416)
38.	Taisuke Yoshida, Motomu Suga, Kunimasa Arima, Yasuko Muranaka, Tsunehiko Tanaka, Satoshi Eguchi, Crystal Lin, Sumiko Yoshida, Masanori Ishikawa, Yuko Higuchi, Tomonori Seo, Yoshinori Ueoka, Masahito Tomotake, Yasuhiro Kaneda, David Darby, Paul Maruff, Masaomi Iyo, Kiyoto Kasai, Teruhiko Higuchi, Tomiki Sumiyoshi, Tetsuro Ohmori, Kiyohisa Takahashi and Kenji Hashimoto : Criterion and Construct Validity of the Cogstate Schizophrenia Battery in Japanese Patients with Schizophrenia, PLoS ONE, Vol.6, No.5, e20469, 2011. (Summary) The CogState Schizophrenia Battery (CSB), a computerized cognitive battery, covers all the same cognitive domains as the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery but is briefer to conduct. The aim of the present study was to evaluate the criterion and construct validity of the Japanese language version of the CSB (CSB-J) in Japanese patients with schizophrenia. Forty Japanese patients with schizophrenia and 40 Japanese healthy controls with matching age, gender, and premorbid intelligence quotient were enrolled. The CSB-J and the Brief Assessment of Cognition in Schizophrenia, Japanese-language version (BACS-J) were performed once. The structure of the CSB-J was also evaluated by a factor analysis. Similar to the BACS-J, the CSB-J was sensitive to cognitive impairment in Japanese patients with schizophrenia. Furthermore, there was a significant positive correlation between the CSB-J composite score and the BACS-J composite score. A factor analysis showed a three-factor model consisting of memory, speed, and social cognition factors. This study suggests that the CSB-J is a useful and rapid automatically administered computerized battery for assessing broad cognitive domains in Japanese patients with schizophrenia. (Keyword) Adult / Aged / Asian Continental Ancestry Group / Case-Control Studies / Cognition / Demography / Female / Humans / Japan / Male / Middle Aged / Neuropsychological Tests / Reproducibility of Results / Schizophrenia / Time Factors / Young Adult (Link to Publication Site) ● Publication site (DOI): 10.1371/journal.pone.0020469 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21637776 ● Summary page in Scopus @ Elsevier: 2-s2.0-79957562563 (DOI: 10.1371/journal.pone.0020469, PubMed: 21637776, Elsevier: Scopus)
39.	Shin-ichi Chiba, Tetsuya Tanioka, Mika Kataoka, Masahito Tomotake and Yuko Yasuhara : PSYCHOMS:COMPUTER MANAGED NURSING-CARE PLANNING SYSTEM AND COMPUTERIZED QUALITY MANAGEMENT OF NURSING OUTCOME, CEBU INTERNATIONAL NURSING CONFERENCE, 54, 2011.
40.	Yoshinori Ueoka, Masahito Tomotake, Tsunehiko Tanaka, Yasuhiro Kaneda, Kyoko Taniguchi, Masahito Nakataki, Shusuke Numata, Shinya Tayoshi, Ken Yamauchi, Satsuki Sumitani, Takashi Ohmori, Shu-ichi Ueno and Tetsuro Ohmori : Quality of life and cognitive dysfunction in people with schizophrenia, Progress in Neuro-Psychopharmacology & Biological Psychiatry, Vol.35, No.1, 53-59, 2011. (Summary) The main purpose of the present study was to examine the relationship between quality of life (QOL) and cognitive dysfunction in schizophrenia. Subjects were 61 stabilized outpatients. Quality of life and cognitive function were assessed using the Quality of Life Scale (QLS) and the Brief Assessment of Cognition in Schizophrenia (BACS), respectively. Clinical symptoms were evaluated with the Positive and Negative Syndrome Scale (PANSS) and the Calgary Depression Scale for Schizophrenia (CDSS). The BACS composite score and the BACS Verbal memory score were positively correlated with the QLS total score and two subscales. The BACS Attention and speed of information processing score had positive correlation with the QLS total and all the subscales scores. The PANSS Positive and Negative syndrome scores also had significant correlations with the QLS total score and all of the subscales. In addition, the CDSS score was negatively correlated with the QLS total score and some of the subscales. Stepwise regression analysis showed that the BACS Attention and speed of information processing score was an independent predictor of the QLS total score but it was less associated with the QLS than the PANSS Negative syndrome score and the CDSS score. The results suggest that negative and depressive symptoms are important factors on patients' QOL and also support the view that cognitive performance provides a determinant of QOL in patients with schizophrenia. (Keyword) Adult / Cognition Disorders / Female / Humans / Male / Middle Aged / Neuropsychological Tests / Predictive Value of Tests / Psychiatric Status Rating Scales / Quality of Life / Questionnaires / Retrospective Studies / Schizophrenia / Young Adult (Link to Publication Site) ● Publication site (DOI): 10.1016/j.pnpbp.2010.08.018 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 20804809 ● Summary page in Scopus @ Elsevier: 2-s2.0-78650960902 (DOI: 10.1016/j.pnpbp.2010.08.018, PubMed: 20804809, Elsevier: Scopus)
41.	Hiroko Kunikata, Yuko Shiraishi, Kazuo Nakajima, Tetsuya Tanioka and Masahito Tomotake : The relationship between psychological comfort space and self-esteem in people with mental disorders, The Journal of Medical Investigation : JMI, Vol.58, No.1-2, 56-62, 2011. (Summary) The purpose of this study was to demonstrate a causal model of the sense of having psychological comfortable space that is call 'ibasho' in Japanese and self-esteem in people with mental disorders who had difficulty in social activities. The subjects were 248 schizophrenia patients who were living in the community and receiving day care treatment. Data were collected from December 2007 to April 2009 using the Scale for the Sense of ibasho for persons with mentally ill (SSI) and the Rosenberg Self-Esteem Scale (RSES), and analyzed for cross-validation of construct validity by conducting covariance structure analysis. A relationship between the sense of having comfortable space and self-esteem was investigated. Multiple indicator models of the sense of having psychological comfortable space and self-esteem were evaluated using structural equation modeling. Furthermore, the SSI scores were compared between the high- and low-self-esteem groups. The path coefficient from the sense of having comfortable space to self-esteem was significant (0.80). High-self-esteem group scored significantly higher in the SSI subscales, 'the sense of recognizing my true self' and 'the sense of recognizing deep person-to-person relationships' than the low-self-esteem group. It was suggested that in order to help people with mental disorders improve self-esteem, it might be useful to support them in a way they can enhance the sense of having comfortable space. (Keyword) Adult / Aged / Aged, 80 and over / Female / Humans / Japan / Male / Middle Aged / Models, Psychological / Questionnaires / Schizophrenic Psychology / Self Concept / social behavior / Young Adult (Tokushima University Institutional Repository) ● Metadata: 80838 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.58.56 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 21372487 ● Search Scopus @ Elsevier (PMID): 21372487 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.58.56 (Tokushima University Institutional Repository: 80838, DOI: 10.2152/jmi.58.56, PubMed: 21372487)
42.	菊地久美子, Masahito Tomotake, Junichi Iga, Shu-ichi Ueno, Minoru Irahara and Tetsuro Ohmori : Psychological features of pregnant women predisposing to depressive state during the perinatal period, Rinsho Seishin Igaku, Vol.39, No.11, 1459-1468, 2010. (Keyword) 周産期 / perinatal period / 抑うつ / depressive state / 心理特性 / psychological features / EPDS / Edinburgh Postnatal Depression Scale (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1523951030100974464 (CiNii: 1523951030100974464)
43.	杉山敏宏, 木村美智子, Tetsuya Tanioka, Masahito Tomotake and 吉田精次 : Support for people with both alcohol dependency and affective disorder, and their families, JNI : The Journal of Nursing Investigation, Vol.9, No.1, 1-6, 2010. (Summary) アルコール依存症と感情障害の関係性は以前から指摘されている．アルコール依存症とうつ病は，自殺企図者の精神障害の内訳の半数を占め，それらが合併した場合には自殺の危険性を一層高める．また，アルコール依存症治療において，患者がうつ症状を呈している場合，再飲酒のリスクが高くなり治療の継続を妨げる原因となりうる．そのため，うつ病の治療にも注意を払うことが求められる．さらに，家族からの支援はアルコール依存症患者の断酒を継続するなどの治療において重要な役割を果たしている．しかし，患者の断酒の継続に注意を払いすぎるあまり，それがストレスとなり患者の問題飲酒を助長することになったり，家族自身がさまざまな悩みを抱え苦しんだりすることが考えられ，家族への支援もとても重要となる．加えて，親がアルコール依存症である場合，子どもも将来アルコール依存症となる危険性が高くなるなど，子どもに与える影響も大きい．そこで医師，看護師，ソーシャルワーカーが支援に関わることや自助グループを活用することが重要となる．本総説ではアルコール依存症と感情障害の関係と治療方法，アルコール依存症と感情障害を抱える患者とその家族への支援に焦点を当て，包括的な支援のありかたを検討した． (Keyword) アルコール依存症 / 感情障害 / うつ病 / 家族支援 / alcohol dependence / affective disorder / depression / family support (Tokushima University Institutional Repository) ● Metadata: 113157 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050020697876398592 (Tokushima University Institutional Repository: 113157, CiNii: 1050020697876398592)
44.	Tetsuya Tanioka, Yuko Yasuhara, Chiemi Kawanishi, 元木一志, 高瀬憲作, Masahito Tomotake, 岩佐幸恵 and 乾達哉 : リスパダールコンスタ専用針を用いた筋肉注射手技の正確性中臀筋への確実な筋肉注射に必要な注射針の検討, The Japanese Journal of Psychiatric Nursing, Vol.38, No.1, 51-57, 2010. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520854804844393472 (CiNii: 1520854804844393472)
45.	Tetsuya Tanioka, 川村亜以, 黒川奈美, 大坂京子, Shin-ichi Chiba, Mika Kataoka, Masahito Tomotake, Yuko Yasuhara, 大森美津子, 川田知子 and 三船和史 : Clinical pathway focused on team care of the behavioral and psychological symptoms of dementia BPSD and family support, Japanese Journal of Geriatric Psychiatry, Vol.21, No.7, 781-788, 2010. (Keyword) 医師; 栄養状態; 家族; 看護師; 行動症状; ソーシャルワーク(精神医学); 退院; 認知症(薬物療法,診断); 日常生活活動; インタビュー; アウトカム評価(保健医療); 抗認知症剤(治療的利用); 社会的支援; クリティカルパス; 作業療法士; 精神症状 / *行動心理学的症候; 精神保健福祉士 / ヒト (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1522543654665999616 (CiNii: 1522543654665999616)
46.	Shusuke Numata, Junichi Iga, Masahito Nakataki, Shinya Tayoshi, Kyoko Taniguchi, Satsuki Sumitani, Masahito Tomotake, Toshihito Tanahashi, Mitsuo Itakura, Yoko Kamegaya, Masahiko Tsutsumi, Akira Sano, Takashi Asada, Hiroshi Kunugi, Shu-ichi Ueno and Tetsuro Ohmori : Gene expression and association analyses of the phosphodiesterase 4B (PDE4B) gene in major depressive disorder in the Japanese population., American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, Vol.150B, No.4, 527-534, 2009. (Summary) The phosphodiesterase 4B (PDE4B) interacts with disrupted-in-schizophrenia 1 (DISC1), which is a known genetic risk factor for schizophrenia, bipolar disorder and major depressive disorder (MDD). PDE4B is also important in the regulation of cAMP signaling, a second messenger implicated in learning, memory, and mood. In this study, we determined mRNA expression levels of the PDE4B gene in the peripheral blood leukocytes of patients with MDD and control subjects (n = 33, each). Next we performed two-stage case-controlled association analyses (first set; case = 174, controls = 348; second set; case = 481, controls = 812) in the Japanese population to determine if the PDE4B gene is implicated in MDD. In the leukocytes, a significantly higher expression of the PDE4B mRNA was observed in the drug-naïve MDD patients compared with control subjects (P < 0.0001) and the expression of the MDD patients significantly decreased after antidepressant treatment (P = 0.030). In the association analysis, we observed significant allelic associations of four SNPs (the most significant, rs472952; P = 0.002) and a significant haplotypic association (permutation P = 0.019) between the PDE4B gene and MDD in the first-set samples. However, we could not confirm these significant associations in the following independent second-set of samples. Our results suggest that the PDE4B gene itself does not link to MDD but the elevated mRNA levels of PDE4B might be implicated in the pathophysiology of MDD. (Keyword) Adult / Aged / Alleles / Case-Control Studies / Cyclic Nucleotide Phosphodiesterases, Type 4 / Depressive Disorder, Major / Female / Gene Expression / Gene Frequency / Genetic Predisposition to Disease / Genotype / Haplotypes / Humans / Japan / Male / Middle Aged / RNA, Messenger (Link to Publication Site) ● Publication site (DOI): 10.1002/ajmg.b.30852 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 18785206 ● Search Scopus @ Elsevier (PMID): 18785206 ● Search Scopus @ Elsevier (DOI): 10.1002/ajmg.b.30852 (DOI: 10.1002/ajmg.b.30852, PubMed: 18785206)
47.	Mayumi YAMAMOTO, Masahito Tomotake and Tetsuro Ohmori : Construction and reliability of the Japanese version of the Adolescent Egocentrism-Sociocentrism(AES) scale and its preliminary application in the Japanese university students, The Journal of Medical Investigation : JMI, Vol.55, No.3 4, 254-259, 2008. (Summary) In recent years, the problem of interpersonal relationships has been reported to be associated with various adolescent psychiatric problems. Egocentrism is one factor related to the problem of interpersonal relationships. The Adolescent Egocentrism-Sociocentrism (AES) scale is used to assess egocentrism in Western countries, but no such scale has been developed in Japan. The purpose of our current study was to develop the Japanese version of the AES scale and investigate the relationship between the egocentrism assessed by the AES scale and the self-consciousness assessed by the Japanese version of the self-consciousness scale. The original version of the AES scale was first translated into Japanese using the forward-backward method and examined for factorial reliability and validity. The results demonstrated that the Japanese version of the AES scale shows adequate factorial reliability and validity, but different from the original version the "egocentrism personal fable" subscale which measures the feeling that oneself is special and unique was not extracted in the Japanese version. We found a moderate correlation between the non-social focuses of the AES scale and the public self-consciousness subscale of the self-consciousness scale. This correlation suggests that a strong attention of others' view on oneself results in the avoidance of others. The Japanese version of the AES scale can examine egocentrism adequately together with sociocentrism and non-social focuses. As this scale is self-reporting and easy to complete, it may have practical utility in a clinical setting. (Keyword) egocentrism / Adolescent egocentrism-sociocentrism / Adolescent Egocentrism-Sociocentrism Scale / self-consciousness (Tokushima University Institutional Repository) ● Metadata: 110868 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.55.254 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 18797140 ● Search Scopus @ Elsevier (PMID): 18797140 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.55.254 (Tokushima University Institutional Repository: 110868, DOI: 10.2152/jmi.55.254, PubMed: 18797140)
48.	Ken Yamauchi, Hirofumi Aki, Masahito Tomotake, Junichi Iga, Shusuke Numata, Ikuyo Motoki, Yumiko Izaki, Shinya Tayoshi, Sawako Kinouchi, Satsuki Sumitani, Sumiko Tayoshi, Yumiko Takikawa, Yasuhiro Kaneda, Takahide Taniguchi, Yasuhito Ishimoto, Shu-ichi Ueno and Tetsuro Ohmori : Predictors of subjective and objective quality of life in outpatients with schizophrenia., Psychiatry and Clinical Neurosciences, Vol.62, No.4, 404-411, 2008. (Summary) AIM: In recent years, greater attention has been given to quality of life (QOL) in schizophrenia and several studies reported that negative and depressive symptoms and cognitive dysfunction are related to patient QOL. But because a variety of QOL measures have been used in the previous studies, there seems to be no unanimous predictors for subjective and objective QOL. The purpose of the present study was to elucidate the relationship between clinical variables and subjective and objective QOL in outpatients with schizophrenia, using schizophrenia disease-specific QOL measures. Particular attention was paid to cognitive function as a predictor of QOL. METHODS: Schizophrenia symptoms of the Positive and Negative Syndrome Scale (PANSS) were divided into five factors: positive factor, negative factor, cognitive factor, emotional discomfort, and hostility. The study sample consisted of 84 schizophrenia outpatients. Subjective and objective QOL were assessed with Schizophrenia Quality of Life Scale (SQLS) and the Quality of Life Scale (QLS), respectively. RESULTS: Subjective QOL correlated significantly with emotional discomfort, positive factor, negative factor, extrapyramidal symptoms and cognitive factor, while objective QOL correlated with negative factor, cognitive factor, emotional discomfort, extrapyramidal symptoms, and dose of antipsychotics. Total score and three of four subscales in the QLS correlated significantly with cognitive factor, while cognitive factor had a significant correlation with only one of three scales of SQLS. Stepwise regression showed that subjective QOL was significantly predicted by emotional discomfort and extrapyramidal symptoms, while negative factor was the most important predictor of objective QOL. CONCLUSION: Cognitive dysfunction had a greater influence on objective QOL than subjective QOL. Treating depressive and negative symptoms and extrapyramidal symptoms might contribute to enhanced subjective and objective QOL. (Keyword) Adult / Affective Symptoms / Ambulatory Care / Antipsychotic Agents / Cognition Disorders / Dose-Response Relationship, Drug / Dyskinesia, Drug-Induced / Female / Humans / Male / Middle Aged / Motivation / Psychiatric Status Rating Scales / quality of life / schizophrenia / Schizophrenic Psychology / Social Adjustment (Link to Publication Site) ● Publication site (DOI): 10.1111/j.1440-1819.2008.01818.x (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 18778437 ● Search Scopus @ Elsevier (PMID): 18778437 ● Search Scopus @ Elsevier (DOI): 10.1111/j.1440-1819.2008.01818.x (DOI: 10.1111/j.1440-1819.2008.01818.x, PubMed: 18778437)
49.	Shusuke Numata, Shu-ichi Ueno, Junichi Iga, Hongwei Song, Masahito Nakataki, Shinya Tayoshi, Satsuki Sumitani, Masahito Tomotake, Mitsuo Itakura, Akira Sano and Tetsuro Ohmori : Positive association of the PDE4B (phosphodiesterase 4B) gene with schizophrenia in the Japanese population., Journal of Psychiatric Research, Vol.43, No.1, 7-12, 2008. (Summary) The phosphodiesterase 4B (PDE4B) gene is located at 1p31, a susceptibility region for schizophrenia (SZ). Moreover, PDE4B interacts with DISC1, which is a known genetic risk factor for SZ. Recently, it was reported that the PDE4B gene is associated with SZ in Caucasian and African American populations. In this study, case-controlled association analyses were performed in the Japanese population to determine if the PDE4B gene is implicated in SZ. Thirteen single nucleotide polymorphisms (SNPs) were analyzed in 444 schizophrenic patients and 452 control subjects. Three SNPs (rs2180335, rs910694 and rs472952) were significantly associated with SZ after applying multiple test correction (p=0.039, 0.004 and 0.028). In addition, a significant association was found between specific haplotypes (rs2180335 and rs910694) and SZ (permutation p=0.001). Our result suggests that variations at the PDE4B locus may play a significant role in the etiology of SZ in the Japanese population. (Keyword) Asian Continental Ancestry Group / Case-Control Studies / Catechol O-Methyltransferase / Chromosome Mapping / Chromosomes, Human, Pair 1 / Control Groups / Cyclic Nucleotide Phosphodiesterases, Type 4 / Female / Gene Frequency / Genetic Markers / Genetic Predisposition to Disease / Genotype / Haplotypes / Humans / Linkage (Genetics) / Linkage Disequilibrium / Male / Middle Aged / Polymorphism, Single Nucleotide / Risk Factors / schizophrenia (Link to Publication Site) ● Publication site (DOI): 10.1016/j.jpsychires.2008.01.013 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 18329668 ● Search Scopus @ Elsevier (PMID): 18329668 ● Search Scopus @ Elsevier (DOI): 10.1016/j.jpsychires.2008.01.013 (DOI: 10.1016/j.jpsychires.2008.01.013, PubMed: 18329668)
50.	Hirofumi Aki, Masahito Tomotake, Yasuhiro Kaneda, Junichi Iga, Sawako Kinouchi, Sumiko Shibuya-Tayoshi, Shin-Ya Tayoshi, Ikuyo Motoki, Kazuhiko Moriguchi, Satsuki Sumitani, Ken Yamauchi, Takahide Taniguchi, Yasuhito Ishimoto, Shu-ichi Ueno and Tetsuro Ohmori : Subjective and objective quality of life, levels of life skills, and their clinical determinants in outpatients with schizophrenia., Psychiatry Research, Vol.158, No.1, 19-25, 2007. (Summary) The purpose of the present study is to investigate the relationships among subjective and objective quality of life (QOL), and levels of life skills, and their clinical determinants in outpatients with schizophrenia by using schizophrenia disease-specific QOL measures. Data collected from 64 outpatients were analyzed. Subjective QOL was measured with the Schizophrenia Quality of Life Scale (SQLS) and objective QOL with the Quality of Life Scale (QLS). Patients' family members completed the Life Skills Profile (LSP). Clinical symptoms were also assessed with several scales including the Brief Psychiatric Rating Scale (BPRS) and the Calgary Depression Scale for Schizophrenia (CDSS). Only the motivation/energy scale, but not the other scales of the SQLS, correlated with the QLS. The LSP rated by the family showed significant correlations with both the SQLS and the QLS. The CDSS score predicted each scale of the SQLS, and the BPRS negative symptoms score predicted the QLS. The LSP was predicted by the BPRS negative symptoms score and the CDSS score independently. These results indicate that the patient's QOL could be predicted by the life skills measured by a family member and suggest that active treatment for depressive and negative symptoms might be recommended to improve the patient's QOL and life skills. (Keyword) Activities of Daily Living / Adult / Ambulatory Care / Brief Psychiatric Rating Scale / Depressive Disorder / Female / Humans / Male / Motivation / Predictive Value of Tests / quality of life / schizophrenia / Schizophrenic Psychology / Severity of Illness Index (Link to Publication Site) ● Publication site (DOI): 10.1016/j.psychres.2006.05.017 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 18160137 ● Summary page in Scopus @ Elsevier: 2-s2.0-38749140984 (DOI: 10.1016/j.psychres.2006.05.017, PubMed: 18160137, Elsevier: Scopus)
51.	Takumi Ikuta, Noriko Furuta, Shouichi Kihara, Masao Okura, Isao Nagamine, Hiroshi Nakayama, Yasuhito Ishimoto, Yasuhiro Kaneda, Masahito Tomotake, Yumiko Izaki and Xu Ming : Differences in waveforms of cerebral evoked potentials among healthy subjects, schizophrenics, manic-depressives and epileptics., The Journal of Medical Investigation : JMI, Vol.54, No.3-4, 303-315, 2007. (Summary) The differences in the waveform of Cerebral EP (Evoked Potential)s; SEP, VEP and AEP, among healthy subjects, schizophrenics, manic-depressives and epileptics were investigated. In 585 subjects of both sexes comprising these diagnostic groups, 6 channels of EPs, each 2 channels for each sensory modality, were recorded simultaneously/parallelly from each subject, without assigning a mental task. Then, waveforms of the g-m (group mean) EPs of each diagnostic group were superimposed for inspection. Peak latencies and inter-peak amplitudes of individual EPs were statistically tested among (ANCOVA) and between (Scheffe's multiple comparison test) these diagnostic groups for each channel (modality), and for each sex. The waveforms of g-m EPs of each diagnostic group differed from each other. The differences of latencies and inter-peak amplitudes among these diagnostic groups attained to the significant level (P<0.05), with more significant differences between healthy subjects and each of these pathological diagnostic groups than between each of these pathological diagnostic groups, for each sex. Thus the differences in the waveform of EPs among these diagnostic groups were confirmed even taking the effect of medication on EPs into consideration. These results might suggest the existence of a waveform for individual EPs specific to each of these diagnostic groups, for each sex. (Keyword) Adolescent / Adult / Aged / Bipolar Disorder / Brain / Case-Control Studies / Child / Epilepsy / Evoked Potentials / Evoked Potentials, Auditory / Evoked Potentials, Somatosensory / Evoked Potentials, Visual / Female / Humans / Male / Middle Aged / Schizophrenia (Tokushima University Institutional Repository) ● Metadata: 111534 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.54.303 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 17878680 ● Search Scopus @ Elsevier (PMID): 17878680 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.54.303 (Tokushima University Institutional Repository: 111534, DOI: 10.2152/jmi.54.303, PubMed: 17878680)
52.	Tetsuya Tanioka, 浦西由美, 山崎里美, 松本正子, 倉橋佳英, Toshiko Tada, 真野元四郎, 山崎正雄, Masahito Tomotake, Yasuko Matsushita, Shu-ichi Ueno, 大森美津子 and 大浦智華 : Survey on Community Resident's Attitudes and Images for Mentally Handicapped Person and Mental Disorder, Nursing Journal of Kagawa University, Vol.11, No.1, 65-74, 2007. (Summary) BACKGROUND: The mental health care and welfare have shifted from hospital care to the community care. Stigma and discrimination with mental health problems have been identified as major obstacles for this plan. AIM: The purpose of this study was to clarify community attitudes and images for mentally handicapped person of the people living in a small community. METHOD: A mail survey was conducted in the area covered by A health center in B prefecture. The candidate 600 residents (2.2% of all residents) who live in B County were selected (age range: 20-60 y.o.). Participants comprised 293 respondents (recovery ratio: 48.8%). RESULTS: About 50% of respondents who are in 20's and 30's answered that they became aware of mentally handicapped persons when they were between elementary school to high school age. The general tendency at that time was negative including "he/she has changed badly" (19.9%) and "he/she is fearful" (15.8%). On the other hand, positive images were less than ten percents including "he/she is not different from an ordinary person"(5.5%), "he/she is friendly personality" (2.3%). The mentally handicapped persons who respondents usually met were only with dementia. CONCLUSION: The images about mental illness at school ages are important. Any intervention aimed at changing attitudes to mentally ill people in the community should be targeted to children. It is also important to make an opportunity of warm interaction between people with mental disorders and community residents in the psychiatric hospital, a rehabilitation institution, etc. (Keyword) 精神障害 / 意識調査 / スティグマ / 偏見 / mental disorder / attitude survey / stigma / social prejudice (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520290883446944512 (CiNii: 1520290883446944512)
53.	Tetsuya Tanioka, 浦西由美, 山崎里美, 松本正子, 倉橋佳英, Fumiko Hashimoto, Toshiko Tada, Yasuko Matsushita, 山崎正雄, 真野元四郎, Masahito Tomotake and Shu-ichi Ueno : Survey on community resident's experiential knowledge of mental disorders and reaction to people with mental disorders, JNI : The Journal of Nursing Investigation, Vol.5, No.2, 91-98, 2007. (Summary) Background : It is essential for mentally disabled persons who live in the community to be understood and cooperated by local residents. Aim : This study investigated the relationship between the participation of the residents to the event held in the psychiatric hospital and their attitudes towards mentally handicapped persons. The research objective is to find the method to the residents for promoting an understanding of mental disorders. Method : A mail survey was conducted in the area covered by the B health center in A prefecture. The candidate600 residents(2 2% of all residents)who live in B county were selected(age range : 20-60 y.o.). Participants comprised 293 respondents(recovery ratio : 48 8%). Comparison was carried out by the respondents who joined or did not join the event held in the psychiatric hospital. Results : Their understanding of mental disorders is relatively high in the participants. Most of them are willing to do something for mentally disabled persons' social rehabilitation. Ten percent of all respondents would choose `can't go along with mentally handicapped persons' social rehabilitation support'. Conclusion : The results suggest that the provision of the opportunity for personal contact with mentally handicapped persons are important for improving the educational activity of the public about mental illnesses and considered to be important measures for promoting the acceptance and support of the mentally handicapped persons by the local residents. (Keyword) mental disorder / people with mental disorder / attitude survey / social rehabilitation / community resident / educational activity (Tokushima University Institutional Repository) ● Metadata: 113126 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050020697876410240 (Tokushima University Institutional Repository: 113126, CiNii: 1050020697876410240)
54.	原田貴史, 中村明美, Masahito Tomotake and Tetsuro Ohmori : The Influence of Obsessive Compulsive Symptoms on Quality of Life among the Female Nursing Staffs, Japanese Journal of Psychosomatic Medicine, Vol.47, No.1, 33-40, 2007. (Summary) Background: The influence of obsessive compulsive symptoms on subjective Quality of Life (QOL) among the woman nursing staff has been scarcely studied. Subject and methods: We examined the correlations of the scores on the Toronto Alexithiymia Scale (TAS-20) with the scores on the Maudsley Obsessive Compulsive Inventory (MOCI). We also assessed the influence of obsessive compulsive symptoms measured by the MOCI or depressive symptoms by the Zung Self-rating Depression Scale (SDS) on subjective QOL by the Brief Version of World Health Organization Quality of Life Assessment (WHO-QOL26) in the staff of 221 female nursing at a general hospital. The correlations of the MOCI or the SDS scores with the WHO-QOL26 total (t-QOL) and the domain scores ("physical", "psychological", "social", and "environmental" domains) were assessed by Spearman rank-correlations. Results: The TAS-20 total scores and the subfactor scores of "Difficulty identifying feelings", and "Difficulty describing feelings" positively correlated with the MOCI scores. Spearman rank-correlations showed negative correlations of the t-QOL with the MOCI and the SDS scores. The MOCI scores revealed significant negative correlations with "physical" and "psychological" but no correlation with "social" and "environmental", though the SDS scores showed significant negative correlations with each domain. The MOCI scores revealed significant negativecorrelations with the t-QOL only in the group in their twenties but the SDS scores showed significant negative correlations with the t-QOL in the group ranging from twenties to fifties. Only in over-fifties-group the MOCI scores revealed positive correlations with "social" domain. Conclusions: Among Japanese female nursing staff in the present study, alexithiymia by the TAS-20 affects on obsessive compulsive symptoms by the MOCI. Both obsessive compulsive symptoms and depressive symptoms had negative effects on their subjective QOL. While depressive symptoms showed negative correlations withsubjective QOL in each age bracket and on each domain, obsessive compulsive symptoms had negative correlations on the subjective QOL only in the younger age group and just on subjective "physical" and "psychological" well-beings. Obsessive compulsive symptoms would improve subjective "social" functioning in the mature age group. (Keyword) nursing staff / alexithiymia / obsessive compulsive symptoms / QOL (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390001204891813760 (CiNii: 1390001204891813760)
55.	Satsuki Sumitani, Shu-ichi Ueno, Yasuhito Ishimoto, Takahide Taniguchi, Masahito Tomotake, Ikuyo Motoki, Ken Yamauchi and Tetsuro Ohmori : Clinical Features of Patients with Obsessive-compulsive Disorder showing Different Pharmacological Responses, Psychiatria et Neurologia Japonica, Vol.108, No.12, 1282-1292, 2006. (Keyword) obsessive-compulsive disorder (OCD) / pharmacological response / clinical feature / selective serotonin reuptake inhibitor (SSRI) / atypical antipsychotic / pharmacological response / clinical feature / selective serotonin reuptake inhibitor / atypical antipsychotic (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1521699230021528192 ● Summary page in Scopus @ Elsevier: 2-s2.0-34047257329 (CiNii: 1521699230021528192, Elsevier: Scopus)
56.	Takahide Taniguchi, Satsuki Sumitani, Michitaka Aono, Junichi Iga, Sawako Kinouchi, Hirosi Aki, Mami Matsushita, Kyoko Taniguchi, Mami Tsuno, Kazunari Yamanishi, Masahito Tomotake, Yasuhiro Kaneda and Tetsuro Ohmori : Effect of antipsychotic replacement with quetiapine on the symptoms and quality of life of schizophrenic patients with extrapyramidal symptoms., Human Psychopharmacology, Vol.21, No.7, 439-445, 2006. (Summary) Replacement of antipsychotic drugs with quetiapine (QTP) was tried in a naturalistic setting in chronic schizophrenic patients who still showed moderate psychiatric symptoms and either showed extrapyramidal symptoms (EPS) or took anti-parkinson drugs for the EPS. QTP was added on and gradually increased while the previous drugs were tapered and discontinued whenever possible. Clinical symptoms, objective and subjective QOL, and EPS were measured before and 6 months after QTP addition, using Brief Psychiatric Rating Scale (BPRS), Quality of Life Scale (QLS), Schizophrenia Quality of Life Scale (SQLS) and Drug-Induced Extrapyramidal Symptom Scale (DIEPSS), respectively. Twenty-one patients completed the trial and received the assessment. It was found that replacement with QTP-improved clinical symptoms, objective and subjective QOL and EPS. This improvement was equally observed in not only patients who switched to QTP monotherapy (n = 11) but also patients who took QTP together with reduced small doses (4.4 +/- 4.3 mg/day) of previous drugs (n = 11). The results suggest that replacement with QTP improves symptoms as well as objective and subjective QOL in a subgroup of schizophrenia. (Keyword) Adolescent / Adult / Antipsychotic Agents / Basal Ganglia Diseases / Dibenzothiazepines / Female / Humans / Male / Middle Aged / Psychiatric Status Rating Scales / Quality of Life / Questionnaires / Schizophrenia / Schizophrenic Psychology / Severity of Illness Index / Treatment Outcome (Link to Publication Site) ● Publication site (DOI): 10.1002/hup.801 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 17029303 ● Search Scopus @ Elsevier (PMID): 17029303 ● Search Scopus @ Elsevier (DOI): 10.1002/hup.801 (DOI: 10.1002/hup.801, PubMed: 17029303)
57.	Masahito Tomotake, Yasuhiro Kaneda, Junichi Iga, Sawako Kinouchi, Sumiko Tayoshi, Ikuyo Motoki, Satsuki Sumitani, Ken Yamauchi, Takahide Taniguchi, Yasuhito Ishimoto, Shu-ichi Ueno and Tetsuro Ohmori : Subjective and objective measures of quality of life have different predictors for people with schizophrenia., Psychological Reports, Vol.99, No.2, 477-487, 2006. (Summary) This study investigated the relationship between subjective and objective quality of life and assessed predictors in people with schizophrenia. The study population consisted of 99 stabilized outpatients with schizophrenia (DSM-IV) who had been regularly receiving outpatient treatment at the Department of Psychiatry, The Tokushima University Hospital. Subjective and objective quality of life were estimated using the Schizophrenia Quality of Life Scale and the Quality of Life Scale, respectively. Psychiatric symptoms were also measured with the Brief Psychiatric Rating Scale and the Calgary Depression Scale for Schizophrenia. Scores on the Schizophrenia Quality of Life Scale Motivation and Energy scales significantly correlated with the Quality of Life Scale total scores -.40 (p <.001), and with the scores on Interpersonal Relations subscale -.42 (p <.001), Instrumental Role subscale -.28 (p = .005), Intrapsychic Foundations subscale -.39 (p<.001), and Common Objects and Activities subscale -.25 (p =.014). The Schizophrenia Quality of Life Scale Psychosocial scale significantly correlated with only the Quality of Life Scale total score -.20 (p =.05), and there was no significant correlation between the scores on the Schizophrenia Quality of Life Scale Symptoms and Side-effects scales and the Quality of Life Scale. Stepwise regression analyses showed that the Calgary Depression Scale for Schizophrenia score was the most important predictor of each scale of the Schizophrenia Quality of Life Scale, and the Brief Psychiatric Rating Scale Negative Symptoms score was the most important predictor of the Quality of Life Scale total score and each subscale. These results suggest that subjective and objective quality of life have different predictors and should be considered as separate and complementary outcome variables. (Keyword) Adult / Ambulatory Care / Brief Psychiatric Rating Scale / Cross-Sectional Studies / Depressive Disorder / Female / Humans / Japan / Male / Middle Aged / Quality of Life / Schizophrenia / Schizophrenic Psychology (Link to Publication Site) ● Publication site (DOI): 10.2466/pr0.99.2.477-487 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 17153817 ● Search Scopus @ Elsevier (PMID): 17153817 ● Search Scopus @ Elsevier (DOI): 10.2466/pr0.99.2.477-487 (DOI: 10.2466/pr0.99.2.477-487, PubMed: 17153817)
58.	Shusuke Numata, Shu-ichi Ueno, Junichi Iga, Ken Yamauchi, Song Hongwei, Koji Ohta, Sawako Kinouchi, Sumiko Shibuya-Tayoshi, Shin'ya Tayoshi, Michitaka Aono, Naomi Kameoka, Satsuki Sumitani, Masahito Tomotake, Yasuhiro Kaneda, Takahide Taniguchi, Yasuhito Ishimoto and Tetsuro Ohmori : Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms., Neuroscience Letters, Vol.401, No.1-2, 1-5, 2006. (Summary) Brain-derived neurotrophic factor (BDNF) is a neurotrophic factor that promotes several functions of neurons and modulates neurotransmissions. It has been reported that there are alterations of BDNF levels in schizophrenic brains and that BDNF gene expressional changes would be responsible for the etiology of schizophrenia. Recent studies have shown that a variation of BDNF gene (Val66Met polymorphism) affects the function of neurons, and is associated with several neurological and psychiatrical disorders. We investigated the relationship between BDNF Val66Met polymorphism and the onset age as well as levels of clinical symptoms in 159 of chronic schizophrenia in-patients diagnosed by DSM-IV. The mean onset ages were 27.5+/-9.5 for BDNF Val/Val, 25.5+/-7.4 for BDNF Val/Met and 22.9+/-6.0 for BDNF Met/Met and this polymorphism was significantly associated with age at onset (P=0.023). The mean Brief Psychiatric Rating Scale scores (BPRS) were significantly different among those three groups (P=0.003). No significant differences were demonstrated comparing the BDNF genotype distributions of positive and negative family history (P=0.21). Our investigation indicates that the BDNF gene Val66Met polymorphism is related to the onset age of schizophrenia and the levels of clinical symptoms that remain after long-term antipsychotic treatment. (Keyword) Adult / Age of Onset / Aged / Amino Acid Substitution / Antipsychotic Agents / brain / Brain Chemistry / Brain-Derived Neurotrophic Factor / DNA Mutational Analysis / Drug Resistance / Female / Gene Frequency / Genetic Predisposition to Disease / Genetic Testing / Genotype / Humans / Male / Methionine / Middle Aged / Polymorphism, Genetic / schizophrenia / Valine (Link to Publication Site) ● Publication site (DOI): 10.1016/j.neulet.2006.02.054 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 16533563 ● Search Scopus @ Elsevier (PMID): 16533563 ● Search Scopus @ Elsevier (DOI): 10.1016/j.neulet.2006.02.054 (DOI: 10.1016/j.neulet.2006.02.054, PubMed: 16533563)
59.	亀岡尚美, Masahito Tomotake and 他 : 自生思考に対して特異な対処行動を示した統合失調症の1例, 精神科, Vol.7, 470-475, 2005.
60.	Nobuyasu Bando, Kumi Watanabe, Masahito Tomotake, Takahide Taniguchi and Tetsuro Ohmori : Central pontine myelinolysis associated with a hypoglycemic coma in anorexia nervosa, General Hospital Psychiatry, Vol.27, No.5, 372-374, 2005. (Keyword) Adult / Anorexia Nervosa / Coma / Female / Humans / Hypoglycemia / Myelinolysis, Central Pontine (Link to Publication Site) ● Publication site (DOI): 10.1016/j.genhosppsych.2005.03.004 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 16168799 ● Search Scopus @ Elsevier (PMID): 16168799 ● Search Scopus @ Elsevier (DOI): 10.1016/j.genhosppsych.2005.03.004 (DOI: 10.1016/j.genhosppsych.2005.03.004, PubMed: 16168799)
61.	武久美奈子, Masahito Tomotake and 他 : 女子大学生の月経前緊張症, CAMPUS HEALTH, 2005.
62.	Hitoshi Nakahira, Masahito Tomotake and Tetsuro Ohmori : Fluvoxamine induced complex partial seizure in the treatment of bulimia nervosa, General Hospital Psychiatry, Vol.27, No.2, 148-150, 2005. (Keyword) Adolescent / Bulimia / Epilepsy, Complex Partial / Female / Fluvoxamine / Humans / Serotonin Uptake Inhibitors (Link to Publication Site) ● Publication site (DOI): 10.1016/j.genhosppsych.2004.11.006 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 15763129 ● Search Scopus @ Elsevier (PMID): 15763129 ● Search Scopus @ Elsevier (DOI): 10.1016/j.genhosppsych.2004.11.006 (DOI: 10.1016/j.genhosppsych.2004.11.006, PubMed: 15763129)
63.	坂東信泰, 渡辺珠美, Masahito Tomotake, Takahide Taniguchi and Tetsuro Ohmori : 低Na血症を認めなかったにもかかわらず中心性橋髄鞘崩壊症を合併した摂食障害の1例, 心療内科, Vol.9, No.2, 137-141, 2005. (Keyword) Central Pontine Myelinolysis / Anorexia Nervosa / Hypoglycemia
64.	原田貴史, Masahito Tomotake, 小笠原一能 and Tetsuro Ohmori : 精神科臨床における下肢深部静脈血栓症, Rinsho Seishin Igaku, Vol.33, No.7, 939-946, 2004. (Keyword) deep vein thrombosis / 向精神薬 / psychotropic drugs / 昏迷状態 / stupor / 脱水状態 / dehydration / 身体拘束 / physical restrain (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1523106604942918912 (CiNii: 1523106604942918912)
65.	Takahide Taniguchi, Masahito Tomotake and Tetsuro Ohmori : バルプロ酸が用量依存的に病相予防効果を発揮した双極性感情障害の1症例, Seishin Igaku, Vol.46, No.2, 161-165, 2004. (Keyword) Bipolar Affective Disorder / Maintenance Treatment / Monotherapy / Therapeutic Drug Monitoring / Valproate (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1523951029495881088 (CiNii: 1523951029495881088)
66.	原田貴史, Masahito Tomotake, Shusuke Numata, Yasuhiro Kaneda and Tetsuro Ohmori : Lithium投与中の甲状腺中毒症(無痛性甲状腺炎), Rinsho Seishin Igaku, Vol.32, No.9, 1101-1108, 2003. (Keyword) lithium / Thyrotoxicosis / Silent thyroiditis / Subclinical Hyperthyroidism (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1523106605563645184 (CiNii: 1523106605563645184)
67.	Masahito Tomotake, Takashi Harada, Yasuhito Ishimoto, Tetsuya Tanioka and Tetsuro Ohmori : Temperament,character,and eating attitudes in japanese college women, Psychological Reports, Vol.92, No.3 Pt 2, 1162-1168, 2003. (Summary) 精神分裂病と本態性パーキンソン病は，前者が脳内ドパミンの過剰仮説により説明されることが多く，後者がドパミン欠乏により生ずることにより，互いに相反する疾患として一般的には理解され，合併することはないと考えられている．しかし，筆者らはその治療経過から，全く相反する疾患として捉える根拠がないことを，その発症機制についての検討を加えて報告した． (Keyword) Adult / Character / culture / Feeding Behavior / Female / Humans / Japan / Questionnaires / Temperament (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 12931935 ● Search Scopus @ Elsevier (PMID): 12931935 (PubMed: 12931935)
68.	原田貴史, Masahito Tomotake and Tetsuro Ohmori : Olanzapineにより知覚変容発作を来した統合失調症の1症例, Seishin Igaku, Vol.45, No.1, 65-68, 2003. (Keyword) Perceptual Alteration Attack / schizophrenia / Olanzapine / Atypical Antipsychotics / Biperiden
69.	Shusuke Numata, Kyoko Taniguchi, Takashi Harada, Masahito Tomotake and Tetsuro Ohmori : Silent thyroiditis associated with short-term lithium therapy, General Hospital Psychiatry, Vol.24, No.6, 451-453, 2002. (Keyword) THYROTOXICOSIS (Link to Publication Site) ● Publication site (DOI): 10.1016/S0163-8343(02)00218-9 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 12490351 ● Search Scopus @ Elsevier (PMID): 12490351 ● Search Scopus @ Elsevier (DOI): 10.1016/S0163-8343(02)00218-9 (DOI: 10.1016/S0163-8343(02)00218-9, PubMed: 12490351)
70.	Masahito Tomotake and Tetsuro Ohmori : Personality profiles in patients with eating disorders, The Journal of Medical Investigation : JMI, Vol.49, No.3-4, 87-96, 2002. (Summary) The present review focused on the personality profiles of patients with eating disorders. Studies using the Structured Clinical Interview for DSM-III-R Personality Disorder showed high rates of diagnostic co-occurrence between eating disorders and personality disorders. The most commonly observed were histrionic, obsessive-compulsive, avoidant, dependent and borderline personality disorders. Studies using the Cloninger's personality theory suggested that high Harm Avoidance might be relevant to the pathology of anorexia nervosa and high Novelty Seeking and Harm Avoidance to bulimia nervosa. Moreover, high Self-Directedness was suggested to be associated with favorable outcome in bulimia nervosa. The assessment of personality in a cross-sectional study, however, might be influenced by the various states of the illness. Therefore, a sophisticated longitudinal study will be required to advance this area of research. (Keyword) Eating Disorder / Personality / SCID-II / TPQ / TCI (Tokushima University Institutional Repository) ● Metadata: 110641 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 12323011 ● CiNii @ National Institute of Informatics (CRID): 1574231876646902016 ● Search Scopus @ Elsevier (PMID): 12323011 (Tokushima University Institutional Repository: 110641, PubMed: 12323011, CiNii: 1574231876646902016)
71.	Takashi Harada, Masahito Tomotake, Akira Ohkubo, Akiyoshi Nishikado, Takashi Yamamoto, Tetsuzo Wakatsuki and Tetsuro Ohmori : Radiofrequency catheter ablation enabled antipsychotic treatment in a schizophrenic patient with idiopathic ventricular tachycardia, General Hospital Psychiatry, Vol.24, No.4, 277-278, 2002. (Keyword) INTERVAL / DRUGS (Link to Publication Site) ● Publication site (DOI): 10.1016/S0163-8343(02)00187-1 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 12100841 ● Search Scopus @ Elsevier (PMID): 12100841 ● Search Scopus @ Elsevier (DOI): 10.1016/S0163-8343(02)00187-1 (DOI: 10.1016/S0163-8343(02)00187-1, PubMed: 12100841)
72.	Masahito Tomotake, Masao Okura, Takahide Taniguchi and Yasuhito Ishimoto : Traits of irrational beliefs related to eating problems in Japanese college women., The Journal of Medical Investigation : JMI, Vol.49, No.1-2, 51-55, 2002. (Summary) This study focused on the relation of irrational beliefs and Body Mass Index (BMI) to inappropriate eating attitudes in Japanese college women. A total of 110 nonclinical subjects completed the Japanese Irrational Belief Test (JIBT) and the Japanese version of the Eating Attitudes Test (EAT). The JIBT subscale of 'self expectation' had significant positive correlations with the EAT total score and the subscales of 'obsession with eating', 'dieting' and 'obese-phobia'. The JIBT subscale of 'dependence' had a significant positive correlation with the EAT subscale of 'obsession with eating'. BMI score showed significant positive correlations with the EAT total score and the subscales of 'dieting' and 'obesephobia'. The present results suggest that characteristic irrational beliefs are associated with inappropriate eating attitudes, suggesting that clarifying and then modifying the irrationality may be a useful method of preventive intervention in nonclinical young women with eating problems. (Keyword) Adult / Attitude / Body Mass Index / Eating Disorders / Female / Humans / Japan / Psychological Tests / Psychotherapy, Rational-Emotive / Students / Universities (Tokushima University Institutional Repository) ● Metadata: 110635 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 11901760 ● Search Scopus @ Elsevier (PMID): 11901760 (Tokushima University Institutional Repository: 110635, PubMed: 11901760)
73.	Masahito Tomotake : 引きこもりを特徴とする対人恐怖症の治療経験, Japanese Journal of Psychiatric Treatment, Vol.16, 1329-1333, 2001.
74.	Masahito Tomotake, 中山浩 and 大森哲郎 : 頑固な食行動障害に fluvoxamine が奏効した最重度精神遅滞を伴う非定型自閉症の1例, Japanese Journal of Psychiatric Treatment, Vol.15, 965-968, 2000.

Academic Paper (Unrefereed Paper):

1.	Mika Kataoka, Kazuhiro Ozawa, Tetsuya Tanioka, Kikuko Okuda, Shin-ichi Chiba, Masahito Tomotake and Beth King : Gender differences of the influential factors on the mental health condition of teachers in the A university., The Journal of Medical Investigation : JMI, Vol.62, No.1-2, 56-61, 2015. (Tokushima University Institutional Repository) ● Metadata: 111247 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.62.56 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 25817285 ● Summary page in Scopus @ Elsevier: 2-s2.0-84925840656 (Tokushima University Institutional Repository: 111247, DOI: 10.2152/jmi.62.56, PubMed: 25817285, Elsevier: Scopus)
2.	Mika Kataoka, Tetsuya Tanioka, Masahito Tomotake and 三船和史 : Effectiveness of nursing interviews using concordance skills aimed at acquisition of self-confidence toward community life for long-stay patients with schizophrenia not wishing to be discharged, Shikoku Acta Medica, Vol.69, No.3,4, 157-164, 2013. (Summary) In the present study, we conducted nursing interviews using concordance skills (CS interviews) aimed at acquisition of self-confidence toward community life for two long-stay patients with schizophrenia who did not wish to be discharged from psychiatric hospital, and evaluated the effectiveness of CS interviews. Case A was a woman in her 70s who was diagnosed with schizophrenia at around age of 17 years and had been institutionalized for approximately 30 years since her ninth admission. Case B was a man in his 30s who was diagnosed with schizophrenia at around age of 22 years and had been admitted 15 times due to auditory hallucination, delusions, suffers a relapse, has been in hospital for two years and six months since his latest admission. As a result of interviews, scores on the Self-Efficacy for Community Life Scale improved from 150 to 160 points for Case A and from 66 to 82 points for Case B. In the Case A, the Global Assessment of Functioning (GAF) score was 35 with no changes before and after intervention. In the case B, GAF score improved from 25 to 35, before and after six months intervention. These findings suggest that CS interviews are effective for promoting self-confidence toward community life among long-stay patients and useful for providing support without exacerbating the severity of psychiatric symptoms or functional level of long-stay patients during the stage in which they nurture the dreams and hopes to be discharged. (Keyword) Concordance skills / Nursing interview / long-stay patients with schizophrenia not wishing to be discharged (Tokushima University Institutional Repository) ● Metadata: 109630 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050020697877665152 (Tokushima University Institutional Repository: 109630, CiNii: 1050020697877665152)
3.	Sakiko Sakamaki, Yuko Yasuhara, Tetsuya Tanioka, Masahito Tomotake, Kazushi Motoki and Kensaku Takase : Relationship between Body Mass Index and Assessment Variables of Intramuscular Injection part of a Gluteal Region, Proceedings of the Sixth International Conference on Information(Info13), 67-72, 2013.
4.	Mika Kataoka, Tetsuya Tanioka and Masahito Tomotake : 精神障害者のためのコンコーダンス・モデルに基づいた新しい看護面接, Shikoku Acta Medica, Vol.69, No.1-2, 57-66, 2013. (Summary) Mental health measures in Japan are moving from hospitalization-centered care to community-based care. With the demand for changes in the functions of psychiatric hospitals and clinics, the role of nurses is growing. The primary role of nursing is to enable each and every individual to maintain a healthy life, which involves providing those individuals with assistance to maximize their vitality and healing capacity and enable them to exploit those abilities as best they can. In order to practice such nursing interview, following basic concepts are useful : (1) It should be based on a concordance model ; (2) It should set opportunities to promote remarks from mentally ill individuals and utilize concordance skills that elicit their thoughts ; and (3) It should utilize the Strengths Assessment Sheet that focuses on lifestyle including the abilities, environment, and hopes of mentally ill individuals. In this article, we describe a proposed new nursing interview framework based on a concordance model for people with mental disorders. (Keyword) concordance model / strengths assessment / nursing interview framework / psychiatric mental health nursing (Tokushima University Institutional Repository) ● Metadata: 109615 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050865122807804032 (Tokushima University Institutional Repository: 109615, CiNii: 1050865122807804032)
5.	Mika Kataoka, Kikuko Okuda, Shin-ichi Chiba, Masahito Tomotake and Toshiko Tada : 総合大学に勤務する教員・研究者を対象にした職務状況とメンタルヘルスに関する実態調査, Japanese Bulletin of Social Psychiatry, Vol.21, No.3, 456, 2012.
6.	Shin-ichi Chiba, 渡部生聖, Tetsuya Tanioka, Yukie Iwasa, 大阪京子, Yuko Yasuhara, Masahito Tomotake, Chiemi Kawanishi, 小笠原坦, 三船和史 and 大森美津子 : 対話による認知症高齢者の自律神経系への影響, 香川大学医学部看護学科紀要, Vol.15, No.1, 27-33, 2011. (Summary) 認知症高齢者と健常者が対話を行う際に，話しの受け手である認知症高齢者の自律神経系にどのような影響があるのかを評価することが目的である．調査協力者はA 介護老人保健施設に入所している認知症高齢者14 名(平均年齢89.43 ± 3.98 才，男性2 名女性12 名，長谷川式簡易知能評価スケールの平均得点は11.79 ± 4.37 点)である．調査協力者と研究者が対話を行い，対話前後の収縮期血圧，拡張期血圧，脈拍，唾液アミラーゼ活性値，体温，SpO2 を測定した．心電図は実験開始とともに記録を開始し，実験終了まで継続して記録した．全ての指標で有意差はみられなかった．しかし，対話前後で唾液アミラーゼ活性値が9 名で低下していた．交感神経機能の指標であるLF/HF は4 名で対話中に上昇し，対話後に低下していた．副交感神経機能の指標であるHF は5 名で対話中に減少していた．認知症高齢者との対話の効果を評価するための生理評価指標として，唾液アミラーゼ活性値，LF/HF が挙げられる資料を得たと考えられた．また日中に効果的な対話を行うことは，認知症高齢者の自律神経活動を，日中は交感神経活動が優位で夜間は副交感神経活動が優位に働くという健常者に類似した自律神経活動に誘導する一助となる資料を得たと考えられた． (Keyword) 対話 / 認知症高齢者 / 唾液アミラーゼ / 心拍変動解析 / 自律神経 / dialogue / dementia / salivary amylase activity / heart rate variability / autonomic nervous (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050006297340565632 (CiNii: 1050006297340565632)
7.	三好真佐美, 下垣内愛, Shin-ichi Chiba, Yuko Yasuhara, 大坂京子, Mika Kataoka, 杉山敏宏, Tetsuya Tanioka, Masahito Tomotake, 佐藤ミサ子 and 三船和史 : 退院支援施設入所後1年が経過した精神障害者の生活能力, JNI : The Journal of Nursing Investigation, Vol.9, No.1, 13-19, 2010. (Summary) 研究目的は，退院促進支援により退院し，退院支援施設で生活した精神障害者の生活能力を明らかにし，看護のあり方を検討することである．調査対象者は，施設入所後1年が経過した長期入院であった精神障害者17名(男性12名，女性5名)で，平均年齢は，52．5歳，平均入院期間は11．3年であった．データ収集は，調査対象者一人ずつに約20分程度の半構成的面接を行った．その結果，逐語録から255のラベルが得られ，11のサブカテゴリーに分類された．これらから「自分自身のペースに合わせた生活リズムの獲得」，「病気を悪化させないための自己管理」，「施設退所後の生活のための心の準備」，「良好な対人関係の構築」という4つのカテゴリーが抽出された．これらの結果から，施設利用者は自分なりのペースで社会復帰に向けての準備をしながら，着実に生活能力を身につけていることが示唆された． (Keyword) people with mental disorders / social hospitalization / discharge support / discharge support center / nursing / life support (Tokushima University Institutional Repository) ● Metadata: 113159 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050583647829818752 (Tokushima University Institutional Repository: 113159, CiNii: 1050583647829818752)
8.	Tetsuya Tanioka, Mika Kataoka, Masahito Tomotake and 三浦宗克 : アリピプラゾールの特徴，利点をふまえた看護のポイント, The Japanese Journal of Psychiatric Nursing, Vol.37, No.9, 35-42, 2010. (Keyword) 看護アセスメント; 精神看護; 生活の質; 統合失調症(薬物療法,看護,合併症); 認知障害(病因,薬物療法,看護); 患者ケア計画; 治療成績; *Aripiprazole(治療的利用); 患者アドヒアランス / クリティカルケア看護 / ヒト; 看護 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1523951030615528064 (CiNii: 1523951030615528064)
9.	Hirofumi Aki, Masahito Tomotake and 他 : 統合失調症患者の主観的QOLと家族による生活技能評価との関連の検討, Annual Report of Mitsubishi Pharma Research Foundation, Vol.37, 169-175, 2005.
10.	Masahito Tomotake and 他 : 統合失調症外来患者のQOLに影響を及ぼす諸要因に関する検討, Annual Report of Mitsubishi Pharma Research Foundation, Vol.36, 145-152, 2004.
11.	Masahito Tomotake and 他 : 新規非定型抗精神病薬による統合失調症の症状とQOLの改善に関する検討, Annual Report of Mitsubishi Pharma Research Foundation, Vol.35, 99-105, 2003.

Review, Commentary:

1.	Masahito Tomotake : 小児摂食障害の治療-最新のエビデンスに基づいて—:認知行動療法とその応用, Journal of Japanese Society of Psychosomatic Pediatrics, Vol.26, 390-391, 2018.
2.	Chikako Kane and Masahito Tomotake : 神経性やせ症のQuality of Lifeについて, Shikoku Acta Medica, Vol.73, No.5-6, 233-240, Dec. 2017. (Summary) Quality of life (QOL) is important as an indicator of recovery of patients with anorexia nervosa (AN). Recently, AN patients' QOL has been investigated from different perspective such as influencing factors. In the present article, using PubMed, the authors performed a search for the research articles that were published between January 1,2000 and December 31,2016 and selected the articles focusing on QOL of patients with AN to review them. As a result of that, it was revealed that AN patients had lower QOL even after recovery than healthy controls and those who still had partial symptoms of eating disorder or had psychiatric comorbidity reported lowered QOL. From the content of QOL subscale, it was revealed that AN patients expressed higher level of dissatisfaction with family environment than patients with other type of eating disorder. Moreover, recently, it has been pointed out that patients with AN might not be able to evaluate their own QOL precisely because of low body weight that could negatively affect their cognitive function and denial of clinical condition. Summing up these findings, the authors suggested that although evaluating QOL is clinically important, we should be careful about the interpretation of the results. (Keyword) anorexia nervosa / eating disorder / quality of life (Tokushima University Institutional Repository) ● Metadata: 112043 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050020697876764032 (Tokushima University Institutional Repository: 112043, CiNii: 1050020697876764032)
3.	安藝敦子 and Masahito Tomotake : 思春期生徒を対象としたユニバーサルタイプの認知行動アプローチの成果と課題, 児童青年精神医学とその近接領域, Vol.56, No.4, 652-665, Aug. 2015.
4.	Masahito Tomotake and Yoshihiro Nakadoi : ABOUT DSM-5 FEEDING AND EATING DISORDERS, Japanese Journal of Child and Adolescent Psychiatry, Vol.55, No.5, 597-604, Nov. 2014. (Keyword) Anorexia Nervosa / Binge-Eating Disorder / Bulimia Nervosa / DSM-5 / Feeding and Eating Disorders (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520572357424384640 (CiNii: 1520572357424384640)
5.	Masahito Tomotake and Yoshihiro Nakadoi : PSYCHOTHERAPY OF EATING DISORDERS, Japanese Journal of Child and Adolescent Psychiatry, Vol.55, 143-151, Apr. 2014. (Keyword) eating disorder / supportive psychotherapy / cognitive behavioral therapy / interpersonal psychotherapy (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520853832417771648 (CiNii: 1520853832417771648)
6.	Masahito Tomotake : 精神科臨床と精神療法, 日本森田療法学会雑誌, Vol.25, 7-11, Apr. 2014. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520853835023348352 (CiNii: 1520853835023348352)
7.	Masahito Tomotake : 摂食障害の臨床-アセスメントと治療の実際-, 小児心身症研究, No.20, 9-13, May 2013.
8.	Masahito Tomotake : Treatment strategy for improving quality of life of schizophrenia patients, Shikoku Acta Medica, Vol.68, No.6, 203-210, Dec. 2012. (Summary) The author reviewed studies on quality of life (QOL) of schizophrenia patients and discussed treatment strategy for improving their QOL. Although schizophrenia patients have been thought to be unable to assess their own QOL because of their cognitive impairment and objective QOL measures have been often used, nowadays, there is general agreement that stabilized patients could evaluate their QOL by themselves and then researchers gradually have become interested in use of subjective QOL measures. As most researchers still tend to assess schizophrenia patients' QOL with only one type of the measures in spite of recent finding that there is a discrepancy between the two types, it would be recommended to use both of them as complementary measures. As for clinical factors related to lowered QOL, it is reported that depressive symptom is associated with lowered subjective QOL and negative symptom with lowered objective one. Moreover, poor life skill is found to be associated with lowered subjective and objective QOL, and several studies report that cognitive dysfunction in some cognitive domains may lead to lowered objective QOL. Generally, it is suggested that reducing depressive and negative symptoms and improving life skill could contribute to enhancement of QOL of schizophrenia patients. (Keyword) schizophrenia / quality of life / life skill / cognitive function (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050020697877520512 (CiNii: 1050020697877520512)
9.	Masahito Tomotake : 摂食障害に対する薬物療法の考え方, Japanese Journal of Psychiatric Treatment, Vol.27, 1429-1434, Nov. 2012.
10.	Masahito Tomotake : 自閉症スペクトラムと摂食障害, 児童青年精神医学とその近接領域, Vol.53, No.4, 501-504, Aug. 2012.
11.	Masahito Tomotake and Tetsuro Ohmori : 精神障害者の幸福感:統合失調症患者のQOLについて, 最新精神医学, Vol.17, 317-322, Jul. 2012.
12.	Masahito Tomotake : Diagnosis and treatment of eating disorders, Shikoku Acta Medica, Vol.68, 19-22, Apr. 2012. (Summary) Eating disorders are common especially in young women nowadays and sometimes can devastatetheir social functions. In diagnosis of eating disorders, clinicians have to pay attention to cooccurrenceof them and other psychiatric disorders such as mood disorder, anxiety disorder, anddevelopmental disorder. To evaluate patients' psychological trait and state precisely, clinicians musthave a good knowledge of the effects of starvation on psychological aspects.The author also highlights that in the treatment of eating disorders, adequate somatic risk assessmentand psychological intervention including motivational enhancement approach and cognitivebehavioral approach are essential. (Keyword) eating disorder / diagnosis / assessment / treatment (Tokushima University Institutional Repository) ● Metadata: 97577 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050302172854630656 (Tokushima University Institutional Repository: 97577, CiNii: 1050302172854630656)
13.	Masahito Tomotake and Tetsuro Ohmori : Outcome measures in the treatment of schizophrenia, Seishin Igaku, Vol.53, No.2, 177-183, Feb. 2011. (Keyword) schizophrenia / Outcome measure / quality of life / Life skill / cognitive function (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390282752363859456 (CiNii: 1390282752363859456)
14.	Masahito Tomotake : 摂食障害について:拒食と過食の心理と治療, めんたるへるす, 2011.
15.	Masahito Tomotake : 摂食障害の精神科治療:心理教育, 日本摂食障害学会, Oct. 2010.
16.	Masahito Tomotake : 最近のうつ病の傾向と抗うつ薬, Expert Nurse, Vol.26, No.6, 76-79, Jun. 2010. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520573328528020480 (CiNii: 1520573328528020480)
17.	Masahito Tomotake : 青年期の自殺, めんたるへるす, Mar. 2008.
18.	Masahito Tomotake, Yasuhiro Kaneda and Tetsuro Ohmori : 主観的QOLの観点からみた統合性失調症の合理的な薬物療法, 精神科, Vol.4, No.3, 171-1758, 2004. (Keyword) Subjective Quality of Life / Objective Quality of Life / schizophrenia
19.	Masahito Tomotake and Tetsuro Ohmori : 統合失調症と抑うつ, Rinsyo Seisin Yakuri, Vol.6, No.11, 1419-1426, 2003. (Keyword) schizophrenia / Depressive Symptom / Diagnosis / Postpsychotic Depression / Pharmacotherapy
20.	Masahito Tomotake and 大森哲郎 : 抗精神病薬関連の体重増加・糖尿病, Japan Medical Journal, Nov. 2002.

Proceeding of International Conference:

1.	Tanioka Ryuichi, Kyoko Osaka, Hirokazu Ito, Zhao Yueren, Masahito Tomotake and Tetsuya Tanioka : Examining Risk Factors for Dynapenia and Sarcopenia in Patients with Schizophrenia, 4TH INTERNATIONAL CONFERENCE ON TECHNOLOGICAL COMPETENCY AS CARING IN NURSING AND HEALTH SCIENCES 2022, ZOOM, Dec. 2022. (Keyword) Dainapenia / Sarcopenia / Schizophrenia / Basal metabolic rate / Total muscle mass / Skeletal muscle mass / Body mass index
2.	M Nakazato, H Startup, H Komatsu, N Numata, K Takebayashi, Y Mochizuki, T Isobe, H Kimura, A Sato, Y Mizuhara, Masahito Tomotake, Y Inaba, Y Kawasaki, U Schmidt and M Iyo : Maudsley model of Anorexia treatment for Japanese Outpatient Randomized controlled trial (MAJOR study) - a study protocol, International Conference on Eating Disorders, Jun. 2022.
3.	Ryuichi Tanioka, Kazuyuki Matsumoto, Kenichi Sugawara, Kensaku Takase, Yoshihiro Kai, Masahito Tomotake and Tetsuya Tanioka : Issues in developing natural language processing applications for healthcare robots to motivate older people while rehabilitation, The 15th NLPKE (NLPKE 2020), Oct. 2020.
4.	Hamatani Sayo, Masahito Tomotake, Tomoya Takeda, Naomi Kameoka, Masashi Kawabata, Hiroko Kubo, Yukio Tada, Yukiko Tomioka, Shinya Watanabe and Tetsuro Ohmori : Characteristics of social cognition in women with anorexia nervosa., London Eating Disorders Confirence., London, Mar. 2017.
5.	Sayo Hamatani, Masahito Tomotake, Tomoya Takeda, Naomi Kameoka, Masashi Kawabata, Hiroko Kubo, Yukio Tada, Yukiko Tomioka, Shinya Watanabe and Tetsuro Ohmori : Impaired social cognition in anorexia nervosa patients, 13th London International Eating Disorders Conference, Vol.12, 2527-2531, London, Mar. 2017. (Summary) The purpose of this study was to investigate the characteristics of social cognition in patients with anorexia nervosa (AN). Eighteen female patients with AN (mean age =35.4±8.6 years) and 18 female healthy controls (HC) (mean age =32.8±9.4 years) participated in the study. Their social cognition was assessed with the Social Cognition Screening Questionnaire (SCSQ). The results showed that total score of the SCSQ and scores of theory of mind and metacognition were significantly lower in AN group than those in HC group. Moreover, significant differences in theory of mind, metacognition, and total score of the SCSQ remained when the effects of depression, anxiety, and starvation were eliminated statistically. These results suggest that patients with AN may have difficulty inferring other people's intention and also monitoring and evaluating their own cognitive activities. Therefore, these features may explain some aspects of the pathology of AN. (Link to Publication Site) ● Publication site (DOI): 10.2147/NDT.S116521 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 27785029 ● Summary page in Scopus @ Elsevier: 2-s2.0-84991583740 (DOI: 10.2147/NDT.S116521, PubMed: 27785029, Elsevier: Scopus)
6.	Sayo Hamatani, Masahito Tomotake, Tomoya Takeda, Chikako Kane and Tetsuro Ohmori : Social cognition in women with eating disorder, 31st International Congress of Psychology, Jul. 2016.
7.	Sayo Hamatani, Masahito Tomotake, Tomoya Takeda, Chikako Kane and Tetsuro Ohmori : Set Shifting and Centarl Coherence in Eating Disorders, 31st International Congress of Psychology, Tokyo, Jul. 2016.
8.	Tomoya Takeda, Sayo Hamatani, M Tamaru, Masahito Tomotake, Motohiro Sakai and Tetsuro Ohmori : Successful cognitive behavioral intervention in a case of psychogenic hearing loss, 8th World Congress of Behavioral and Cognitive Therapies, Jun. 2016.
9.	Tomoya Takeda, Masahito Tomotake, Yoshinori Ueoka, T Tanaka, Takeo Tominaga, Yasuhiro Kaneda and Tetsuro Ohmori : Relationship between cognitive function and employment in Japanese schizophrenia patients, 8th World Congress of Behavioral and Cognitive Therapies, Jun. 2016.
10.	Yoshihiro Nakadoi and Masahito Tomotake : The treatment outcome of inpatients with anorexia nervosa restricting subtype in a Japanese National Children's Hospital, 16th International Congress of ESCAP (European Society for Child and Adolescent Psychiatry), Madrid, Spain, Jun. 2015.
11.	Akira Nishi, Shusuke Numata, Atsushi Tajima, Kumiko Kikuchi, Makoto Kinoshita, Shinji Shimodera, Masahito Tomotake, Issei Imoto and Tetsuro Ohmori : Total plasma homocysteine and schizophrenia: gender and MTHFR C677T genotypes., Neuroscience, San Diego, Nov. 2013.
12.	Yoshihiro Nakadoi, Mai Tamaru, Naoki Yamada, Yukie Futagawa and Masahito Tomotake : The characteristics of eating disorder inpatients in a Japanese National children's hospital, 15th International Congress of ESCAP (European Society for Child and Adolescent Psychiatry), Jul. 2013.
13.	Masahito Tomotake, Yoshihiro Nakadoi, Shin-ichi Chiba and Mika Kataoka : Development of a new motivational workbook for the treatment of anorexia nervosa, 15th International Congress of ESCAP(European Society for Child and Adolescent Psychiatry), Ireland, Jul. 2013.
14.	Masahito Tomotake, Shin-ichi Chiba, Mika Kataoka, Nozomi Nishio, Hiroko Hirano, Chie Imaizumi, Aki Suemasa, Akane Tokubo and Yoshihiro Nakadoi : Relation between disordered eating, sense of trust and perceived parenting in young women, 15th International Congress of ESCAP(European Society for Child and Adolescent Psychiatry), Ireland, Jul. 2013.
15.	Shusuke Numata, Kumiko Kikuchi, Atsushi Tajima, Makoto Kinoshita, Shinji Shimodera, Masahito Tomotake, Issei Imoto and Tetsuro Ohmori : Plasma homocysteine and schizophrenia: A gender-specific meta-analysis., 11th world congress of biological psychiatry, Kyoto, Jun. 2013.
16.	Sakiko Sakamaki, Yuko Yasuhara, Tetsuya Tanioka, Masahito Tomotake, Kazushi Motoki and Kensaku Takase : Relationship between Body Mass Index and Assessment Variables of Intramuscular Injection part of a Gluteal Region, The Sixth International Conference on Information(Info13), Tokyo, May 2013.
17.	Yoshihiro Nakadoi, Naomi Kameoka, Masahito Tomotake and Tetsuro Ohmori : The characteristics of eating disorder inpatients in a Japanese university hospital, IACAPAP 20th World Congress, Paris, Jul. 2012.
18.	Yoshihiro Nakadoi, Naomi Kameoka, Masahito Tomotake and Tetsuro Ohmori : The characteristics of eating disorder inpatients in a Japanese university hospital, IACAPAP 20th World Congress, Paris, Jul. 2012.
19.	Tetsuya Tanioka, Yuko Yasuhara, Chiemi Kawanishi, 元木一志, 高瀬憲作, Masahito Tomotake, Keiko Sekido, Shigeru Sato and Tatsuya Inui : Accurate water-soluble depot intramuscular injection techique and ultrasound evaluation, CEBU INTERNATIONAL NURSING CONFERENCE, 5-55, Apr. 2011.
20.	Masahito Tomotake, 上岡義典, 田中恒彦, Yasuhiro Kaneda and Tetsuro Ohmori : Effect of cognitive dysfunction on subjective quality of life in people with schizophrenia, British Association for Behavioural & Cognitive Psychotherapies: 38th BABCP Annual Conference & Workshops, Manchester, Jul. 2010.
21.	Masahito Tomotake and 他 : Cognitive restructuring of negative old memories of parents was effective in the treatment of an adolescent patient with marked social withdrawal, British Association for Behavioural & Cognitive Psychotherapies: 38th Annual Conference, Manchester, UK, Jul. 2010.
22.	Masahito Tomotake, Yoshinori Ueoka, Tsunehiko Tanaka, Yasuhiro Kaneda and Tetsuro Ohmori : Effect of cognitive dysfunction on subjective quality of life in people with schizophrenia, British Association for Behavioural & Cognitive Psycho-Therapies 38th Annual Conference & Workshop, 2010.
23.	Yoshinori Ueoka, Masahito Tomotake, Tsunehiko Tanaka, Yasuhiro Kaneda, Masahito Nakataki, Satsuki Sumitani, Shu-ichi Ueno and Tetsuro Ohmori : Quality of Life and Cognitive Dysfunction in People with Schizophrenia, The 1st Meeting of the Asian College of Neuropsychopharmacology, Nov. 2009.
24.	Tsunehiko Tanaka, Yoshinori Ueoka, Masahito Tomotake, Yasuhiro Kaneda and Tetsuro Ohmori : Relationship between Cognitive Function and Clinical Symptoms in People with Schizophrenia, The 1st Meeting of the Asian College of Neuropsychopharmacology, Nov. 2009.
25.	Yoshinori Ueoka, Masahito Tomotake and 他 : Quality of life and cognitive dysfunction in people with schizophrenia, 1st As CNP, Kyoto, Nov. 2009.
26.	Tsunehiko Tanaka, Yoshinori Ueoka, Masahito Tomotake and 他 : Relationship between cognitive function and clinical symptoms in people with schizophrenia, 1st As CNP, Kyoto, Nov. 2009.
27.	Yoshinori Ueoka, Masahito Tomotake, Tsunehiko Tanaka, Yasuhiro Kaneda, Kazusa Kawahara, Hatsumi Iwasaki, Ai Okamoto, Ayumi Hase, Mai Ikebuchi, Natsuki Mori, Keiko Momo and Tetsuro Ohmori : Clinical factors related to cognitive function in people with schizophrenia, XIV World Congress of Psychiatry, Sep. 2008.
28.	Masahito Tomotake, Yoshinori Ueoka, Tsunehiko Tanaka, Yasuhiro Kaneda, Ken Yamauchi, Kyoko Taniguchi, Yumiko Takikawa, Masahito Nakataki, Shusuke Numata, Shinya Tayoshi, Satsuki Sumitani, Yumiko Izaki, Takashi Ohmori, Shu-ichi Ueno and Tetsuro Ohmori : Subjective quality of life and cognitive function in people with schizophrenia, XIV World Congress of Psychiatry, Sep. 2008.
29.	Yoshinori Ueoka, Masahito Tomotake, Tsunehiko Tanaka, Yasuhiro Kaneda, Ken Yamauchi, Kyoko Taniguchi, Yumiko Takikawa, Masahito Nakataki, Shusuke Numata, Shinya Tayoshi, Satsuki Sumitani, Yumiko Izaki, Takashi Ohmori, Shu-ichi Ueno and Tetsuro Ohmori : Predictors of objective quality of life in people with schizophrenia, XIV World Congress of Psychiatry, Sep. 2008.
30.	Yoshinori Ueoka, Masahito Tomotake and 他 : Predictors of objective quality of life in people with schizophrenia, 14th World Congress of Psychiatry, Prague, Sep. 2008.
31.	Yoshinori Ueoka, Masahito Tomotake and 他 : Clinical factors related to cognitive function in people with schizophrenia, 14th World Congress of Psychiatry, Prague, Sep. 2008.
32.	Hirofumi Aki, Masahito Tomotake and 他 : Subjective well-being and its clinical determinants in outpatients with schizophrenia, 14th World Congress of Psychiatry, Prague, Sep. 2008.
33.	Masahito Tomotake and 他 : Subjective quality of life and cognitive function in people with schizophrenia, 14th World Congress of Psychiatry, Prague, Sep. 2008.
34.	Hirofumi Aki, Masahito Tomotake and 他 : Clinical determinants of quality of life in outpatients with schizophrenia, 5th World Congress of Behavioural & Cognitive Therapies, Barcelona, Jul. 2007.
35.	Masahito Tomotake and 他 : Comparison of subjective quality of life between good and poor insight groups in people with schizophrenia, 5th World Congress of Behavioural & Cognitive Therapies, Barcelona, Jul. 2007.
36.	Nobuyasu Bando, Kumi Watanabe, Masahito Tomotake, Takahide Taniguchi and et al. : Central pontine myelinolysis associated with a hypoglycemic coma in anorexia nervosa, 18th World Congress on Psychosomatic Medicine, Aug. 2005.
37.	Takashi Harada, A Nakamura, Masahito Tomotake and 他 : The influence of obsessive compulsive symptoms measured by the Maudsley Obsessive Compulsive Inventory (MOCI) on quality of life by brief version of World Health Organization Quality of LIFE Assessment (WHO-QOL26) among the woman nursing staffs, 18th World Congress on Psychosomatic Medicine, Kobe, Aug. 2005.
38.	Takashi Harada, A Nakamura, Masahito Tomotake and 他 : The relationship of personality dimensions measured with the Temperament and Character Inventory (TCI) and quality of life measured using the brief version of the World Health Organization Quality of Life Assessment (WHO QOL 26) among the Japanese nursing staffs at K general hospital, 11th Congress of the Asian College of Psychosomatic Medicine, Okinawa, Oct. 2004.
39.	Takashi Harada, Masahito Tomotake and 他 : Pulmonary thromboembolism due to deep vein thrombosis of the leg associated with physical restraints to psychiatric inpatient; a review report, 11th Congress of the Asian College of Psychosomatic Medicine, Okinawa, Oct. 2004.
40.	Satsuki Sumitani, Mami Matsushita, Kayoko Wada, Masahito Tomotake, Shu-ichi Ueno, Taketoshi Yamashita, Shinichi Matsumoto, Ryuji Kaji and Tetsuro Ohmori : Comparison of the temperament between obsessive-compulsive disorder and idiopathic dystonia, CINP, Paris, Jun. 2004.
41.	Masahito Tomotake and 他 : Subjective and objective measures of quality of life have different symptomatic determinants in people with schizophrenia, 24th CINP, Paris, Jun. 2004.
42.	Takahide Taniguchi, 他, Masahito Tomotake and 他 : Effect of antipsychotic replacement with quetiapine on the symptoms and QOL of schizophrenic patients, 24th CINP, Paris, Jun. 2004.
43.	Masahito Tomotake and 他 : Personality and eating attitudes in college women, 12 th World Congress of Psychiatry, Yokohama, Aug. 2002.
44.	Takashi Harada, Masahito Tomotake and 他 : Treatment of IVT enabled antipsychotic use, 12 th World Congress of Psychiatry, Yokohama, Aug. 2002.
45.	Shusuke Numata, Masahito Tomotake, K Taniguchi, T Harada and Tetsuro Ohmori : Short-term lithium therapy induced silent thyroiditis, 12 th World Congress of Psychiatry, Yokohama, Aug. 2002.
46.	Harada Takashi, Masahito Tomotake and 他 : Social anxiety and perceived parenting in Japanese women, 12 th World Congress of Psychiatry, Yokohama, Aug. 2002.
47.	Masao Okura, Masahito Tomotake and 他 : Traits of socially desirable ego state in Japanese young women, ECPR 2000 C/O Congress Conference AS, Oslo-Norway, Jun. 2000.

Proceeding of Domestic Conference:

1.	Masahito Tomotake, 中里道子, 水原祐起 and 沼田法子 : 〈研修会〉モーズレイ神経性やせ症治療(Maudsley Model of Anorexia Nervosa Treatment for Adults : MANTRA) 研修会, 第27回日本摂食障害学会学術集会, Sep. 2024.
2.	Masahito Tomotake, 水原祐起 and 中里道子 : モーズレイ神経性やせ症治療(MANTRA)研修会:Maudsley Model of Anorexia Treatment for Adults (MANTRA), 第26回日本摂食障害学会学術集会, Oct. 2023.
3.	Shin-ichi Chiba, Rie Tsutsumi and Masahito Tomotake : 視線解析技術を用いた統合失調症模擬患者における精神科看護師の観察技術の検討, 第266回徳島医学会学術集会, 36, Feb. 2023. (Keyword) 視線解析 / 精神看護 / 観察
4.	石井良宗, Masahito Tomotake, Shin-ichi Chiba, Rie Tsutsumi, 青野将知 and 田口浩資郎 : 入院中の統合失調症患者におけるQuality of Life，認知機能，臨床要因の関連についての研究, 第263回徳島医学会学術集会, Aug. 2021.
5.	Masahito Tomotake : <シンポジウム:人格の病理としての摂食障害痩せすぎモデル規制に向けて> 力動的精神療法的視点から, 第22回日本摂食障害学会, Nov. 2018.
6.	Takeo Tominaga, Masahito Tomotake, Tomoya Takeda and Tetsuro Ohmori : 統合失調症患者の生活技能と関連する要因の検討~認知機能を中心に~, 第13回統合失調症学会, Mar. 2018.
7.	Masahito Tomotake : 日本精神神経学会生涯教育研修会:摂食障害診療の基本, 第58回中国・四国精神神経学会, Nov. 2017.
8.	Rie Tsutsumi, Masahito Tomotake and Shin-ichi Chiba : 女子大学生における月経随伴症状とQOLの関連についての検討, 第41回中国・四国精神保健学会, Nov. 2017.
9.	Chikako Kane, Masahito Tomotake, Sayo Hamatani and Tetsuro Ohmori : 神経性やせ症患者のレジリエンスに影響を及ぼす臨床要因, 第58回日本児童青年精神医学会, Oct. 2017.
10.	Chikako Kane, Masahito Tomotake, Sayo Hamatani and Tetsuro Ohmori : 神経性やせ症患者のQOLに影響を及ぼす臨床要因, 第58回日本児童青年精神医学会, Oct. 2017.
11.	Masahito Tomotake : <シンポジウム:小児摂食障害の治療>認知行動療法とその応用, 第35回日本小児心身医学会, Sep. 2017.
12.	Shin-ichi Chiba, Masahito Tomotake, 青野将知, 利光秀文 and Tetsuro Ohmori : 入院中の統合失調症患者における認知機能と精神症状，基本的な社会生活機能の関連性の検討, 第255回徳島医学会学術集会プログラム抄録集, 31, Aug. 2017. (Keyword) 入院中 / 統合失調症 / 認知機能 / 社会生活機能 / 精神症状
13.	Takeo Tominaga, Masahito Tomotake, Tomoya Takeda and Tetsuro Ohmori : 統合失調症患者の認知機能と社会機能の関連, 第12回日本統合失調症学会, Mar. 2017.
14.	Reiko Okahisa, Yumi Kuwamura, Kumi Takahashi, Sachiko Masuya, Sachi Kishida, Masahito Tomotake, Tetsuya Tanioka and Rozzano De Castro Locsin : 看護大学生が短期留学で体験したフィンランド看護教育におけるアクティブ・ラーニング, 大学教育カンファレンスin 徳島抄録集, Dec. 2016. (Keyword) 看護大学生 / 短期留学 / フィンランド看護教育 / アクティブ・ラーニング
15.	Sayo Hamatani, Masahito Tomotake, Tomoya Takeda and Tetsuro Ohmori : 神経性無食欲症患者における社会認知の特性, 第20回日本摂食障害学会, Oct. 2016.
16.	Sayo Hamatani, Masahito Tomotake, Hidehiro Umehara, Tomoya Takeda and Tetsuro Ohmori : 児童養護施設で暮らす小6男児の癇癪弱化と職員へのペアレントトレーニング, 第42回日本認知・行動療法学会, Oct. 2016.
17.	Masahito Tomotake : 重症摂食障害への精神分析的接触の試み, 日本精神分析的精神医学会第14回大会, Mar. 2016.
18.	Shin-ichi Chiba, Masahito Tomotake, Masatomo Aono, Hidefumi Toshimitsu and Tetsuro Ohmori : 入院中の統合失調症患者の基本的な社会生活機能に関連した臨床症状, 第252回徳島医学会学術集会, Feb. 2016.
19.	Sayo Hamatani, Masahito Tomotake, Tomoya Takeda, 四方めぐみ and Tetsuro Ohmori : 摂食障害患者におけるP-Fスタディの特徴, 第19回摂食障害学会, Oct. 2015.
20.	安藝敦子 and Masahito Tomotake : 思春期のストレスマネジメント短期教育プログラム後の抑うつ症状とQOLの変化, 第56回日本児童青年精神医学会, Sep. 2015.
21.	安藝敦子 and Masahito Tomotake : 中学生における学校ベースの認知行動教育プログラム実施後の抑うつ症状とQOLの変化, 第15回日本認知療法学会, Jul. 2015.
22.	Masahito Tomotake : ひきこもり事例への認知療療法的介⼊, 第99回徳島認知・行動療法研究会, Apr. 2015.
23.	Takeo Tominaga, Masahito Tomotake, Yoshinori Ueoka and Tetsuro Ohmori : 統合失調症患者における病識と認知機能との関連, 第14回精神疾患と認知機能研究会, Nov. 2014.
24.	Masahito Tomotake : 摂食障害治療における薬物療法の考え方, 第17回日本摂食障害学会, Nov. 2013.
25.	Yoshinori Ueoka, 田中恒彦, Masahito Tomotake, Yasuhiro Kaneda and Tetsuro Ohmori : 統合失調症患者の主観的QOLに及ぼす認知機能障害の影響, 第13回精神疾患と認知機能研究会, Nov. 2013.
26.	Masahito Tomotake : 精神科臨床と精神療法, 第31回日本森田療法学会, Nov. 2013.
27.	Yoshihiro Nakadoi and Masahito Tomotake : 香川小児病院における摂食障害患者に対する入院治療の検討, 第54回日本児童青年精神医学会, Oct. 2013.
28.	生田奈央, 高島啓, 原知也, Takayuki Ise, 西條良仁, 高木恵理, 門田宗之, 太田理絵, 齋藤友子, Mika Bando, 坂東左知子, 松浦朋美, 發知淳子, Takeshi Tobiume, Koji Yamaguchi, Shusuke Yagi, Takashi Iwase, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Masataka Sata, Michio Shimabukuro, Daiju Fukuda and Masahito Tomotake : 心身症として見過ごされていた体位性起立頻脈症候群を的確に診断・治療し得た一例, 第247回徳島医学会学術集会, Aug. 2013.
29.	Takeo Tominaga, Masahito Tomotake, 上岡義典 and Tetsuro Ohmori : 統合失調症患者の病識と認知機能との関連, 第8回日本統合失調症学会, Apr. 2013.
30.	Takeo Tominaga, Masahito Tomotake, 上岡義典 and Tetsuro Ohmori : 統合失調症患者の認知機能と病識との関連, 第9回統合失調症研究会, Feb. 2013.
31.	Takeo Tominaga, Masahito Tomotake, Yoshinori Ueoka and Tetsuro Ohmori : 統合失調症患者の認知機能と病識との関連, 第9回統合失調症研究会, Feb. 2013.
32.	Masahito Tomotake : 変化のステージ・モデルからみた精神療法の特徴と実践的活用, 森田療法研究会, Jan. 2013.
33.	Masahito Tomotake : <シンポジウム>心の問題の発症準備状態の子どもの理解と予防:うつと不安の予防について, 第2回子どもの心の問題発症予防研究会, Dec. 2012.
34.	Yoshihiro Nakadoi, Naomi Kameoka, Masahito Tomotake and Tetsuro Ohmori : 徳島大学病院における摂食障害患者の入院治療の検討, 第53回日本児童青年精神医学会, Oct. 2012.
35.	Masahito Tomotake : Quality of Life の向上を目指した統合失調症治療, 第245回徳島医学会学術集会, Jul. 2012.
36.	Masahito Tomotake : (教育講演)摂食障害の臨床 -アセスメントと治療の実際-, 第20回日本小児心身医学会中国四国地方会, May 2012.
37.	Masahito Tomotake, Takeo Tominaga, 上岡義典 and Tetsuro Ohmori : 家族から見た統合失調症患者の日常生活技能と認知機能障害との関連, 第7回日本統合失調症学会, Mar. 2012.
38.	Mika Kataoka, Kikuko Okuda, Shin-ichi Chiba, Masahito Tomotake and Toshiko Tada : 総合大学に勤務する教員・研究者を対象にした職務状況とメンタルヘルスに関する実態調査, 第31回日本社会精神医学会抄録, 124, Mar. 2012.
39.	Masahito Tomotake, Takeo Tominaga, Yoshinori Ueoka and Tetsuro Ohmori : 家族から見た統合失調症患者の日常生活技能と認知機能障害との関連, 第8回統合失調症研究会, Feb. 2012.
40.	Masahito Tomotake, Takeo Tominaga, 上岡義典 and Tetsuro Ohmori : 家族から見た統合失調症患者の日常生活技能と認知機能障害との関連, 第8回統合失調症研究会, Feb. 2012.
41.	Naomi Kameoka, Yoshihiro Nakadoi, Masahito Tomotake and Tetsuro Ohmori : 摂食障害患者にみられるRefeeding syndromeについて, 第244回徳島医学会, Feb. 2012.
42.	Masahito Tomotake : メンタルヘルスと栄養:摂食障害について, 第244回徳島医学会, Feb. 2012.
43.	上岡義典, 田中恒彦, Masahito Tomotake, Yasuhiro Kaneda and Tetsuro Ohmori : 統合失調症における認知機能と主観的および客観的QOLの関連, 第11回精神疾患と認知機能研究会, Nov. 2011.
44.	Yoshinori Ueoka, 田中恒彦, Masahito Tomotake, Yasuhiro Kaneda and Tetsuro Ohmori : 統合失調症における認知機能と主観的および客観的QOLの関連, 第11回精神疾患と認知機能研究会, Nov. 2011.
45.	Masahito Tomotake : 自閉症スペクトラムと青年成人期精神障害の接点:自閉症スペクトラムと摂食障害, 第52回日本児童青年精神医学会, Nov. 2011.
46.	Yoshihiro Nakadoi, Naomi Kameoka, Masahito Tomotake and Tetsuro Ohmori : 徳島大学病院精神科における摂食障害患者の入院治療の検討, 第52回日本児童青年精神医学会, Nov. 2011.
47.	田中恒彦 and Masahito Tomotake : flooding法の使いどころを考える∼段階的exposureでは治療が停滞した中学男児の事例より∼, 第11回日本認知療法学会, Sep. 2011.
48.	吉田泰介, 管心, 有馬邦正, 村中泰子, 田中恒彦, Lin Crystal, 吉田寿美子, 石川正憲, 樋口悠子, 瀬尾友徳, Yoshinori Ueoka, Masahito Tomotake, Yasuhiro Kaneda, Darby David, Paul Maruff, 伊豫雅臣, 笠井清登, 樋口輝彦, 住吉太幹, Tetsuro Ohmori, 高橋清久 and 橋本謙二 : Cogstate統合失調症バッテリー日本語版の妥当性, 第33回日本生物学的精神医学会, May 2011.
49.	Masahito Tomotake : (Symposium) Relation among cognitive dysfunction, quality of life and clinical symptoms in schizophrenia patients, 第20回日本臨床精神神経薬理学会・第40回日本神経精神薬理学会合同年会, Sep. 2010.
50.	Yoshinori Ueoka, Masahito Tomotake, Tsunehiko Tanaka, Yasuhiro Kaneda, Masahito Nakataki, Shusuke Numata, Shinya Tayoshi, Satsuki Sumitani, Takashi Ohmori, Shu-ichi Ueno and Tetsuro Ohmori : Subjective Quality of Life and Cognitive Function in Outpatients with Schizophrenia, 第5回日本統合失調症学会, Mar. 2010.
51.	Yoshinori Ueoka, Masahito Tomotake and et al. : Subjective quality of life and cognitive function in outpatients with schizophrenia, 第5回日本統合失調症学会, Mar. 2010.
52.	Yoshinori Ueoka, Masahito Tomotake, Tsunehiko Tanaka, Yasuhiro Kaneda, Masahito Nakataki, Satsuki Sumitani, Shu-ichi Ueno and Tetsuro Ohmori : Quality of Life and Cognitive Dysfunction in People with Schizophrenia, 第19回日本臨床精神神経薬理学会・第39回日本神経精神薬理学会合同年会, Nov. 2009.
53.	Tsunehiko Tanaka, Yoshinori Ueoka, Masahito Tomotake, Yasuhiro Kaneda and Tetsuro Ohmori : Relationship between Cognitive Function and Clinical Symptoms in People with Schizophrenia, 第19回日本臨床精神神経薬理学会・第39回日本神経精神薬理学会合同年会, Nov. 2009.
54.	Yoshihiro Nakadoi, 長尾智子, 井上麻由, Shusuke Numata, Satsuki Sumitani, Masahito Tomotake and Tetsuro Ohmori : 抗精神病薬が有効であった高次脳機能障害を合併した神経性無食欲症の1例, 第50回中国四国精神神経学会, Nov. 2009.
55.	Masahito Tomotake : うつ病の予防と治療における留意点, 第53回中国四国合同産業衛生学会, Nov. 2009.
56.	Naomi Kameoka, Masahito Tomotake and 他 : 摂食障害患者に見られる Refeeding syndrome について, 第29回日本精神科診断学会, Oct. 2009.
57.	高田恵里, 佐平安紀子, Masahito Tomotake and Tetsuro Ohmori : 外来患者を対象とした個別作業療法 ∼開設から5年間の取り組み∼, 第32回中国・四国精神保健学会, Nov. 2008.
58.	Masahito Tomotake, Yoshinori Ueoka, Tsunehiko Tanaka, Yasuhiro Kaneda, Ken Yamauchi, Kyoko Taniguchi, Takikawa Yumiko, Masahito Nakataki, Shusuke Numata, Shinya Tayoshi, Satsuki Sumitani, Yumiko Izaki, Takashi Ohmori, Shu-ichi Ueno and Tetsuro Ohmori : Quality of life and cognitive function in outpatients with schizophrenia, 第18回日本臨床精神神経薬理学会・第38回日本神経精神薬理学会合同年会, Oct. 2008.
59.	Yoshinori Ueoka, Masahito Tomotake, Tsunehiko Tanaka, Yasuhiro Kaneda, Masahito Nakataki, Shusuke Numata, Shinya Tayoshi, Satsuki Sumitani, Yumiko Izaki, Takashi Ohmori, Shu-ichi Ueno and Tetsuro Ohmori : Relationship between cognitive function and clinical factors in people with schizophrenia, 第18回日本臨床精神神経薬理学会・第38回日本神経精神薬理学会合同年会, Oct. 2008.
60.	Masahito Tomotake : 摂食障害治療の実際 -心理的なアプローチを中心に-, 徳島県臨床心理士研究会, Oct. 2008.
61.	Ueoka Yoshinori, Masahito Tomotake, Tanaka Tsunehiko, Yasuhiro Kaneda and al et : Relationship between cognitive function and clinical factors in people with schizophrenia, 第18回日本臨床精神神経薬理学会, Oct. 2008.
62.	Masahito Tomotake, Yoshinori Ueoka, Tsunehiko Tanaka, Yasuhiro Kaneda and et al. : Quality of life and cognitive function in outpatients with schizophrenia, 第18回日本臨床精神神経薬理学会, Oct. 2008.
63.	Masahito Tomotake : 徳島大学病院におけるセルトラリンの使用経験, 第197回精翠会研究会, Jun. 2008.
64.	Masahito Tomotake : モーズレイ摂食障害ユニットで学んだこと, 第5回摂食障害懇話会, Mar. 2008.
65.	Yoshinori Ueoka, Yasuhiro Kaneda, 田中恒彦, Shusuke Numata, Ken Yamauchi, Masahito Tomotake and Tetsuro Ohmori : 統合失調症認知機能簡易評価尺度(BACS)による認知機能の評価とその臨床症状との関連, 第4回統合失調症研究会, Feb. 2008.
66.	上岡義典, 田中恒彦, Yasuhiro Kaneda, Shusuke Numata, Ken Yamauchi, Masahito Tomotake and Tetsuro Ohmori : 統合失調症認知機能簡易評価尺度(BACS)による認知機能の評価とその臨床症状との関連, 第4回統合失調症学会, Feb. 2008.
67.	今井麻由, Kumiko Kawabata, 徳原直子, 瀧川裕美子, Masahito Tomotake and Tetsuro Ohmori : 幻聴の訴えのため統合失調症が疑われた解離性障害の一例, 第48回中国・四国精神神経学会, Nov. 2007.
68.	Yoshinori Ueoka, 椎野広久, Yumiko Izaki, 上岡千世, Masahito Tomotake and Tetsuro Ohmori : K-ABCからみたアスペルガー障害幼児の認知特性, 第27回日本精神科診断学会, Oct. 2007.
69.	Masahito Tomotake : 児童青年期の精神科診断学;摂食障害, 第27回日本精神科診断学会, Oct. 2007.
70.	Mayumi YAMAMOTO, Masahito Tomotake and Tetsuro Ohmori : AES日本語版の作成ならびに自己中心性と自意識との関連の検討, 第27回日本精神科診断学会, Oct. 2007.
71.	Yumiko Izaki, Naomi Kameoka, Masahito Tomotake and 他 : 徳島大学病院における児童思春期患者の外来新患調査, 第27回日本精神科診断学会, Oct. 2007.
72.	Masahito Tomotake, Hirofumi Aki, Ken Yamauchi and 他 : 統合失調症外来患者の主観的QOLと病識の有無に関する検討, 第27回日本精神科診断学会, Oct. 2007.
73.	Hirofumi Aki, Masahito Tomotake, Ken Yamauchi and 他 : 統合失調症患者のQOLに影響を与える要因の関する研究, 第27回日本精神科診断学会, Oct. 2007.
74.	Ken Yamauchi, Hirofumi Aki, Masahito Tomotake and 他 : 統合失調症患者の主観的及び客観的QOLに与える要因についての検討 -認知機能障害がQOLに与える影響について-, 第27回日本精神科診断学会, Oct. 2007.
75.	Masahito Tomotake : (教育セミナー)摂食障害の認知行動療法, 第3回日本摂食障害学会, Oct. 2007.
76.	Yumiko Izaki, Masahito Tomotake and Tetsuro Ohmori : 小中学校時に不登校経験があり青年期以降に大うつ病エピソードをきたした3例, 第48回日本児童青年精神医学会, Oct. 2007.
77.	Shusuke Numata, Shu-ichi Ueno, Junichi Iga, Ken Yamauchi, Hongwei Song, Koji Ohta, Sawako Kinouchi, Sumiko Tayoshi, Shinya Tayoshi, Michitaka Aono, Naomi Kameoka, Satsuki Sumitani, Masahito Tomotake, Yasuhiro Kaneda, Takahide Taniguchi, Yasuhito Ishimoto and Tetsuro Ohmori : Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age of onset, The 2nd Annual Meeting of Japanse Society of Schizophrenia Research, Mar. 2007.
78.	Syusuke Numata, Shu-ichi Ueno, Junichi Iga, Ken Yamauchi, Hongwei So, Koshi Ohta, Sawako Kinouchi, Sumiko Shibuya-Tayoshi, Shinya Tayoshi, Michitaka Aono, Naomi Kameoka, Satsuki Sumitani, Masahito Tomotake and et al : Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset, 第2回日本統合失調症学会, Mar. 2007.
79.	Satsuki Sumitani, Shu-ichi Ueno, Yasuhito Ishimoto, Takahide Taniguchi, Masahito Tomotake and 他 : OCDのSSRIと非定型抗精神病薬に対する応答性と臨床特徴について, 第8回OCD研究会, Nov. 2006.
80.	Ken Yamauchi, Hirofumi Aki, Masahito Tomotake and 他 : 統合失調症患者の主観的及び客観的QOLに与える要因についての検討, 第102回日本精神神経学会, May 2006.
81.	Hirofumi Aki, Masahito Tomotake, Yasuhiro Kaneda and 他 : 統合失調症外来患者の服用内容とQOLおよび生活技能評価との関連の検討, 第15回日本臨床精神神経薬理学会, Oct. 2005.
82.	Naomi Kameoka, Masahito Tomotake, Takahide Taniguchi and 他 : 診断・治療に苦慮した統合失調症の一例, 第46回中国四国・精神神経学会, Oct. 2005.
83.	Masahito Tomotake, Hirofumi Aki, Yasuhiro Kaneda and 他 : 統合失調症外来患者の主観的ウェルビーイングと関連する臨床的諸要因についての検討, 第101回日本精神神経学会, May 2005.
84.	Hirofumi Aki, Masahito Tomotake, Yasuhiro Kaneda and 他 : 統合失調症外来患者の服用内容とQOL-定型薬服用群と非定型薬服用群の比較-, 第101回日本精神神経学会, May 2005.
85.	Hirofumi Aki, Masahito Tomotake, Yasuhiro Kaneda and 他 : 統合失調症患者の主観的及び客観的QOLと家族による生活技能評価との関連の検討, 第37回精神神経系薬物治療研究報告会, Dec. 2004.
86.	武久美奈子, Masahito Tomotake and 他 : 女子大学生の月経前緊張症 ― アンケート調査より ―, 第42回全国大学保健管理研究集会, Oct. 2004.
87.	坂東伸泰, 渡辺球美, Masahito Tomotake and 他 : 低Na血症を認めなかったにも関わらず中心性橋髄鞘崩壊症を合併した摂食障害の1例, 第28回日本心身医学会中国・四国地方会, Oct. 2004.
88.	Hirofumi Aki, Masahito Tomotake, Yasuhiro Kaneda and 他 : 統合失調症外来患者の服薬内容とQOL ― 定型薬服用群と非定型薬服用群の比較 ―, 第14回日本臨床精神神経薬理学会, Sep. 2004.
89.	Ken Yamauchi, Junichi Iga, 宋鴻偉, Masahito Tomotake and 他 : 更年期外来におけるSSRIの使用経験-パロキセチン投与についての予備的検討, 第26回日本生物学的精神医学会, Jul. 2004.
90.	Masahito Tomotake, Junichi Iga, Sawako Kinouchi and 他 : 統合失調症外来患者の主観的QOLと客観的QOL, 第100回日本精神神経学会, May 2004.
91.	原田貴史, Masahito Tomotake, 中村明美 and 他 : 女性看護職員におけるMOCIによる強迫症状とTCIによる人格特性との関係, 第100回日本精神神経学会, May 2004.
92.	Masahito Tomotake and 他 : 統合失調症外来患者のQOLに影響を及ぼす諸要因に関する検討, 第36回精神神経系薬物治療研究報告会, Dec. 2003.
93.	原田貴史, Masahito Tomotake, Shusuke Numata, Yasuhiro Kaneda and Tetsuro Ohmori : リチウム投与により甲状腺中毒症が生じた時の対応について, 第16回日本総合病院精神医学会, Nov. 2003.
94.	原田貴史, Masahito Tomotake and 他 : 下肢深部静脈血栓症を生じたうつ病の2症例, 第16回日本総合病院精神医学会, Nov. 2003.
95.	原田貴史, Masahito Tomotake and 他 : リチウム投与により甲状腺中毒症が生じたときの対応について, 第16回日本総合病院精神医学会, Nov. 2003.
96.	Takahide Taniguchi, Masahito Tomotake and 他 : バルプロ酸が用量依存的に病相予防効果を発揮した双極性感情障害の1症例, 第44回中国・四国精神神経学会, Nov. 2003.
97.	Masahito Tomotake and 他 : 女性の更年期障害に対してのパロキセチン使用経験, 第13回日本臨床精神神経薬理学会, Oct. 2003.
98.	Yasuhito Ishimoto, Masahito Tomotake and 他 : 大学生の社会不安症状と被養育体験内容および生活の満足度との関連, 第41回全国大学保健管理研究集会, Oct. 2003.
99.	Yasuhito Ishimoto, Masahito Tomotake and 他 : 大学新入生の精神健康状態に関するアンケート調査, 第41回全国大学保健管理研究集会, Oct. 2003.
100.	原田貴史, Masahito Tomotake and 他 : うつ病治療中の深部静脈血栓症の2例, 第27回日本心身医学会中国・四国地方会, Oct. 2003.
101.	Masahito Tomotake : 更年期障害に対するパロキセチンの使用経験, 第27回日本心身医学会中国・四国地方会, Oct. 2003.
102.	中平仁, Masahito Tomotake and 他 : Fluvoxamine投与中に複雑部分発作をきたした神経性大食症の1症例, 第99回日本精神神経学会, May 2003.
103.	Masahito Tomotake and 他 : 大学生の生活の質(QOL)に影響を与える諸要因に関する検討, 第99回日本精神神経学会, May 2003.
104.	Satsuki Sumitani, 松下真美, 和田香代子, Masahito Tomotake and 他 : TCIを用いたOCDと特発性ジストニアのパーソナリティーの比較, 第99回日本精神神経学会, May 2003.
105.	Yasuhito Ishimoto, Yoshihiro Nakadoi, 谷口京子, Masahito Tomotake and 他 : 脳血管障害後のうつ状態についてのアンケート調査, 第8回日本神経精神医学会, Apr. 2003.
106.	Masahito Tomotake : 摂食障害の症例, 第67回徳島認知療法研究会, Apr. 2003.
107.	Yasuhito Ishimoto, Yoshihiro Nakadoi, 谷口京子, Masahito Tomotake and 他 : 脳血管障害後のうつ状態についてのアンケート調査, 第4回ムードディスオーダー・カンファレンス, Mar. 2003.
108.	Masahito Tomotake and 他 : 新規非定型抗精神病薬による統合失調症の症状とQOLの改善に関する検討, 第35回精神神経系薬物治療研究報告会, Dec. 2002.
109.	原田貴史, Masahito Tomotake and 他 : オランザピン増量と関連して知覚変容発作を来した統合失調症の1症例, 第14回西日本精神神経学会, Nov. 2002.
110.	Takahide Taniguchi, Masahito Tomotake and 他 : 初回治療を行った進行麻痺の6症例, 第14回西日本精神神経学会, Nov. 2002.
111.	Satsuki Sumitani, 松下真美, 和田香代子, Masahito Tomotake and 他 : TCIを用いたOCDとジストニアのパーソナリティーの比較, 第4回OCD研究会, Nov. 2002.
112.	Hiroshi Nakayama, Masahito Tomotake and 他 : 児童精神科病棟に望まれる構造に関するアンケート調査, 第43回日本児童青年精神医学会, Nov. 2002.
113.	Masahito Tomotake and 他 : 青年期女性の摂食態度，社会不安，強迫に関する調査‐被養育体験との関連について‐, 第26回日本心身医学会中国四国地方会, Oct. 2002.
114.	原田貴史, 犬伏大地, 谷口京子, Shusuke Numata, 青野成孝, Masahito Tomotake and 他 : 炭酸リチウム投与中に甲状腺中毒症を生じた3例, 第26回日本心身医学会中国四国地方会, Oct. 2002.
115.	Masahito Tomotake : 不登校・リストカットを主訴に来院した思春期の1例, 第1回徳島児童青年精神保健研究会, Jun. 2002.
116.	Masahito Tomotake and 他 : 顕著な引きこもりを呈した社会恐怖症患者の治療経験, 第3回ムードディスオーダー・カンファレンス, Mar. 2002.
117.	原田貴史, Masahito Tomotake and 他 : 特発性心室頻拍症を合併し高周波カテーテル焼灼術後に，抗精神病薬療法が可能となった精神分裂病の1例, 第25回日本心身医学会中国・四国地方会, Oct. 2001.
118.	Masahito Tomotake : 非定型自閉症児のこだわり行動についての治療経験, 第2回 OCD 研究会, Nov. 2000.
119.	Hirofumi Aki, Masahito Tomotake and 他 : ペニシリン持続点滴大量静注療法を施行した進行麻痺の1症例, 第220回徳島医学会, Jan. 2000.

Et cetera, Workshop:

1.	Sayo Hamatani, Masahito Tomotake, Tomoya Takeda and Tetsuro Ohmori : 神経性無食欲症患者における社会認知の特性, 第16回精神疾患と認知機能研究会, Nov. 2016.
2.	Yoshie Imai, Misako Nakagawa, 滝本理沙, Kazuya Kondo, 坂東孝枝, Chiemi Onishi, 笹三徳, Yukiko Tadokoro, Akira Tangoku, Keiko Mori, Masahito Tomotake, Shoichiro Takao, Junji Ueno, 高橋雅子, 廣瀬千恵子 and 久岡園花 : ホルモン受容体陽性閉経後乳癌に対するアロマターゼ阻害(AI)剤投与前後の症状とQOLの変化, 第69回徳島乳腺研究会, Apr. 2014.
3.	Takeo Tominaga, Masahito Tomotake, 上岡義典 and Tetsuro Ohmori : 統合失調症患者の認知機能と病識との関連, 第9回統合失調症研究会, Feb. 2013.
4.	Yoshihiro Nakadoi, Naomi Kameoka, Masahito Tomotake and Tetsuro Ohmori : 摂食障害徳島大学病院精神科における摂食障害患者の入院治療の検討, 日本児童青年精神医学会総会抄録集, Vol.52, 334, 2011.
5.	Shusuke Numata, Masahito Nakataki, Junichi Iga, Shinya Tayoshi, 谷口京子, Satsuki Sumitani, Masahito Tomotake and 他 : 大うつ病の末梢白血球におけるPDE4B遺伝子の発現と関連研究, 第41回精神神経系薬物治療研究報告会, Dec. 2008.
6.	Hiromichi Okabe, Masahito Tomotake and Tetsuro Ohmori : 自殺率の低い地域の特性解明, 自殺対策のための戦略研究発表会, Feb. 2007.
7.	Tetsuro Ohmori, Masahito Tomotake, Yasuhito Ishimoto and 他 : 自殺率の低い地域の特性解明, 自殺対策のための戦略研究発表会, Jun. 2006.
8.	原田貴史, Shusuke Numata, Yasuhiro Kaneda, Masahito Tomotake and 他 : リチウム投与中の甲状腺中毒症について, 第23回リチウム研究会, Apr. 2003.
9.	Shusuke Numata, Masahito Tomotake, 谷口京子, 原田貴史 and Tetsuro Ohmori : 炭酸リチウム投与後早期に無痛性甲状腺炎をきたした重症うつ病の1症例, 第22回リチウム研究会, Apr. 2002.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

Development of simplified assessment index in order to estimate distance from the epidermis to the under-fascia (DEUF) for reliable intramuscular injection (Project/Area Number: 23660100 )
Development and evaluation of a motivational worksheet in the inpatient treatment of anorexia nervosa (Project/Area Number: 23593440 )
A study of treatment strategies for obsessive-compulsive disorder by using cognitive performance and functional neuroimagings (Project/Area Number: 23591709 )
Psychiatric Outcome Management System Using Clinical Pathways : Development, Evaluation, and Improvement (Project/Area Number: 20390544 )
青年期後期人口におけるうつ病既往の実態と発症と関連する諸要因についての調査研究 (Project/Area Number: 15790625 )
Longitudinal study on psychiatric disorders with reference to the expression of stress-related genes. (Project/Area Number: 14570927 )
Search by Researcher Number (50294682)

Professor : Tomotake, Masahito

Research

Field of Study

Subject of Study

Book / Paper

Book:

Academic Paper (Judged Full Paper):

Academic Paper (Unrefereed Paper):

Review, Commentary:

Proceeding of International Conference:

Proceeding of Domestic Conference:

Et cetera, Workshop:

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)